ๆญฏ์ž„์ˆ˜๋นˆ.PDF

Size: px
Start display at page:

Download "ๆญฏ์ž„์ˆ˜๋นˆ.PDF"

Transcription

1 HPV DNA chip The clinical significance of HPV DNA chip test in the management of Atypical Squamous Cells of Undetermined Significance

2 HPV DNA chip The clinical significance of HPV DNA chip test in the management of Atypical Squamous Cells of Undetermined Significance

3

4 Abstract List of tables I II III IV V

5 : ( ASCUS, Atypical squamous cells of undetermined significance ),. ASCUS, ASCUS HPV DNA chip. : ASCUS, HPV DNA chip,, 48. HPV DNA chip 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, : ASCUS 48 ( CIN II ) % 5

6 . 48 HPV DNA %. HPV DNA, 30.6%( 11/36 ), ( CIN I ) 33.3%( 1/3 ), ( CIN II ) 80%( 4/5 ), ( CIN III ) 100%( 2/2 ), 100%( 2/2 ). HPV DNA. HPV DNA chip, HPV DNA 88.9%, 69.2%, 96.4%, 40%. : ASCUS HPV DNA chip. 6

7 Abstract Objective: Cervical intraepithelial neoplasia ( CIN ) and invasive cervix cancer were detected in some case of Atypical squamous cells of undetermined significance ( ASCUS ) PAP smear. In this study, we attempted to assess the clinical significance of a cytologic diagnosis of ASCUS and determine the usefulness of HPV DNA chip test ( new diagnostic method for HPV ) in management and evaluation of ASCUS patients. Methods : This study was performed from 1. November 2001 to 30. June 2002 and included 48 cases of ASCUS who were evaluated by HPV DNA chip test and whose pathology was evaluated by punch biopsy, cone biopsy or hysterectomy. The result of type 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68 and 69 in HPV DNA chip test were categorized as high risk. Results: The detection rate of pathology of above CIN II in ASCUS was 18.8%( 9/48 ). The detection rate of high risk HPV DNA in ASCUS was 41.7%( 20/48 ). The detection rate of high risk HPV DNA in WNL or Reactive was 30.6%( 11/36 ), 33.3%( 1/3 ) in CIN I, 80%( 4/5 ) in CIN II, 100%( 2/2 ) in CIN III, 100%( 2/2 ) in invasive cervix cancer. Higher the grade of pathology, more the detection rate of high risk HPV DNA chip test. The sensitivity for 7

8 the prediction of pathology of above CIN II by HPV DNA chip test was 88.9% and specificity, negative predictive value, positive predictive value were 69.2%, 96.4% and 40%. Conclusion: The use of HPV DNA chip test in patients with ASCUS may provide usefulness in detection of pathology of CIN II, III and invasive cervix cancer. 8

9 List of tables Table 1. Age distribution of the patients of ASCUS Table 2. Pathologic diagnosis of ASCUS Table 3. High risk HPV detection rate in each pathologic diagnosis Table 4. Type of HPV in normal and CIN I patients Table 5. Type of HPV in CIN II, CIN III and invasive cancer patients Table 6. Correlation of pathologic diagnosis and high risk HPV DNA detection 9

10 I Papanicolaou, 1., 6-55% ( NCI ) The Bethesda system ( TBS ) ( ASCUS, Atypical squamous cells of undetermined significance ), ( LSIL ), ( HSIL ) TBS ( Atypical squamous cells ) ASC-UC ( Atypical squamous cells of undetermined significance ) ASC-H ( Atypcial squamous cells, cannot exclude HSIL ). (ASC ) ( reactive ) 10

11 ( SIL ) 5-13%,. ( human papilloma virus ).,... Hybrid Capture II.,, HPV DNA chip HPV DNA ASCUS. 11

12 II ( ASCUS ), HPV DNA chip ( punch biopsy ), ( cone biopsy ), 48., HPV DNA chip,,. HPV DNA chip 1. 12

13 2. cytobrush. HPV speculum cytobrush ( ) Neodin TM PCR kit. HPV DNA Neodin TM PCR kit 22 HPV type specific oligonucleotide probe gamma-globin probe, probe DNA ( target DNA ) PCR ( hybridization ). probe streptavidin-r-phycoerythrin dye HPV. HPV DNA chip 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, , 11, 34,40, 42, ,,. 13

14 3. 48.,,,,,. HPV DNA chip. 4. Fisher's exact test P value

15 III ( Table 1 ). 2. ASCUS ASCUS (75.0%), ( CIN I ) 3 ( 6.2% ), ( CIN II ) 5 ( 10.4% ), ( CIN III ) 2 ( 4.2% ), 2 ( 4.2% ) ( Table 2 ) %. 15

16 3. HPV DNA 48 HPV DNA %. HPV DNA, 11 ( 30.6% ), 1 ( 33.3% ), 4 ( 80% ), 2 ( 100% ), 2 ( 100% ) ( Table 3). HPV DNA. HPV DNA 100%. 4. HPV DNA HPV DNA HPV DNA. HPV DNA 16 18, ( Table 4 ). 16

17 5. HPV DNA HPV DNA %, % ( Table 5 ). 6. HPV DNA,,. HPV DNA %, HPV DNA %. HPV DNA %, HPV DNA % ( Table 6 ). ASCUS HPV DNA chip 88.9%, 69.2%, 96.4%, 17

18 40%, HPV DNA P value

19 Table 1. Age distribution of the patients of ASCUS Age of patients No. of patients(%) ( 16.7 ) ( 22.9 ) ( 31.2 ) ( 14.6 ) ( 12.5 ) ( 2.1 ) Total 48 ( 100 ) 19

20 Table 2. Pathologic diagnosis of ASCUS* Pathologic diagnosis No. of patients(%) Normal or reactive 36 (75 ) CIN I ** 3 (6.2 ) CIN II 5 (10.4 ) CIN III 2 (4.2 ) Invasive cancer 2 (4.2 ) Total 48(100) *ASCUS : Atypical squamous cells of undetermined significance **CIN : Cervical intraepithelial neoplasia 20

21 Table 3. High risk HPV* detection rate in each pathologic diagnosis Pathologic diagnosis No.of cases No.of patients of high risk (%) Normal or reactive (30.6 ) CIN I** 3 1 (33.3) CIN II 5 4 (80 ) CIN III 2 2 (100) Invasive cancer 2 2 (100) Total (41.7 ) *HPV : Human papillomavirus **CIN : Cervical intraepithelial neoplasia 21

22 Table 4. Type of HPV in Normal and CIN I patients Case No HPV** DNA type Pathologic diagnosis 1 6* Normal or Reactive 2 16 Normal or Reactive 3 18 CIN I*** 4 40* Normal or Reactive 5 51 Normal or Reactive 6 56 Normal or Reactive 7 58 Normal or Reactive 8 58 Normal or Reactive 9 68 Normal or Reactive 10 51,58 Normal or Reactive 11 45,66 Normal or Reactive 12 66,68 Normal or Reactive 13 35,42 Normal or Reactive 14 16,18,34 Normal or Reactive *low risk type HPV **HPV: Human papillomavirus ***CIN : Cervical intraepithelial neoplasia 22

23 Table 5. Type of HPV in CIN II, CIN III and invasive cancer patients Case No HPV *DNA type Pathologic diagnosis 1 16 CIN II** 2 16 CIN II 3 16 Invasive cancer 4 18 CIN III 5 45 CIN II 6 35 CIN II 7 33,35 Invasive cancer 8 33,51 CIN III *HPV: Human papillomavirus **CIN: Cervical intraepithelial neoplasia 23

24 Table 6. Correlation of pathologic diagnosis and high risk HPV DNA detection High risk HPV* DNA Pathologic diagnosis CIN I** CIN II Total (%) (%) (%) Negative 27 ( 69.2 ) 1 ( 11.1 ) 28 ( 58.3 ) Positive 12 ( 30.8 ) 8 ( 88.9 ) 20 ( 41.7 ) Total 39 (100) 9 (100) 48(100) *HPV: Human papillomavirus **CIN: Cervical intraepithelial neoplasia 24

25 IV. 12%, 1.. CIN I, CIN II, CIN III, CIS,,..,,, HPV DNA,,,., Papanicolaou I, II, III, IV, V

26 Papanicolaou Traut,,., % 2.,,.,,, 1988 Bethesda ( NCI ) PAP class II The Bethesda system ( TBS ). TBS,,,. TBS ASCUS, 26

27 ( LSIL ), ( HSIL ) 3. HPV, ASCUS. ASCUS,,, HPV, koilocytotic atypia TBS ASCUS ( Reactive ), ( SIL ), Papanicolaou class II,,,,, HPV.. ASCUS, 27

28 2-3,,, TBS ASCUS fabor reactive ( ), fabor SIL ( ), NOS ( not otherwise specified ) TBS ASCUS,,,, ASCUS., ASCUS ( ASC, Atypical squamous cell ). ASC SIL. ASC ASC-US ASC-H ASC-US ( Atypical squamous cells of undetermined significance ) SIL SIL ASCUS, fabor reactive ASCUS, NOS ASCUS, fabor SIL, ASC 95%. ASC-H ( Atypical squamous cells, cannot exclude HSIL ) HSIL HSIL 28

29 HSIL CIN II, CIN III ASC-US CIN II, CIN III ASC-US. ASC-H ASC 5-10%. ASC ASC 5%, SIL ASC ASC:SIL 2:1 3:1 5. ASCUS 2-11% 6., ASCUS %, %, % ASCUS 1.98%. ASCUS ASCUS 46.2%, 53.8% 10. ASCUS 10, ASCUS 29

30 5-13% 11. ASCUS,,,,,,, HPV DNA 12., ASCUS , ASCCP ASC-US ASC-H, ASC-US,, HPV DNA. HPV DNA 30

31 , SIL, ASC-H. 1960, 1980 ( HPV, Human papillomavirus ), HPV,, %. 99% 1 HPV. HPV, HPV, HPV. HPV 6, 11, 42, 43, 44 condyloma, HPV 16, 18 31

32 , HPV 31, 33, 35, 39, 45, 51, 52, 56, HPV E5, E7 HPV 18. HPV DNA 16 18, 31, 45., HPV HPV. HPV viral particle, HPV typing 100 HPV HPV HPV DNA HPV DNA. HPV DNA Liquid hybridization ( Hybrid capture system ) HPV type specific probe Dot blot hybridization, Southern blot hybridization, Filter in situ hybridization, HPV DNA 32

33 type specific PCR, general primer PCR, general primer set HPV DNA Dot blot hybridization, Microtiter plate hybridization, Line probe assay. HPV DNA, HPV DNA. HPV DNA chip HPV 22 type ( High risk group; 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, 69 Low risk group; 6, 11, 34, 40, 42, 43, 44 ), HPV. HPV DNA,,,,,, scanner HPV DNA,. 33

34 HPV 3 HSIL. HPV HSIL,,. HPV borderline smear 21. HPV DNA. ASCUS HPV DNA LSIL, HPV DNA HSIL 22. Apgar ASCUS HPV DNA, HPV DNA,, 34

35 23. Cox ASCUS HPV DNA CIN II CIN III 93%, 27% 22. Hatch ASCUS CIN II CIN III HPV DNA 60% 24. HPV DNA ASCUS 25. Gideon ASCUS CIN II CIN III 24.6%., ASCUS HPV DNA CIN II CIN III 85.7%, 97%. HPV DNA CIN II CIN III 87%, 95.7% 24.6% 26. ASCUS HPV DNA CIN II 35

36 88.9%, 69.2% 41.7%. HPV, HPV DNA chip. ASCUS HPV DNA chip 6. Lorincz ASCUS DNA HPV, HPV DNA SIL, HPV DNA 6 HPV DNA 27. ASCUS HPV 36

37 ,, HPV, HPV. ASCUS HPV DNA, HPV 30, HSIL HPV DNA 31. HPV DNA HPV DNA,

38 V ASCUS, HPV DNA chip,, HPV DNA. 1. ASCUS %. ASCUS 18.8% HPV DNA %. HPV DNA, 38

39 11 ( 30.6% ), 1 ( 33.3% ), 4 ( 80% ), 2 ( 100% ), 2 ( 100% ). HPV DNA. 3. HPV CIN II 16, 18. ASCUS. 4.,,. HPV DNA %, HPV DNA %. HPV DNA %, HPV DNA %. ASCUS HPV DNA chip 88.9%, 39

40 69.2%, 96.4%, 40%, HPV DNA P value ASCUS HPV DNA chip,. 16, 18. HPV DNA chip. 40

41 1. Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 1989 Feb 3; 261(5): Soost HJ, Lange HJ, Lehmacher W, Ruffing-Kullmann B. The validation of cervical cytology. Sensitivity, specificity and predictive values. Acta Cytol 1991 Jan-Feb; 35(1): The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop. Acta Cytol 1992 May-Jun; 36(3): Solomon D, Frahle WJ, et al. ASCUS and AGUS Critera, IAC Task Force Summary. Acta Cytol 1998; 42: Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA 1994 Jun 15; 271(23): Pearlstone AC. Grigsby PW. Mutch DG. High rates of atypical cervical cytology: Occurence and clinical significance. Obstet Gynecol 1992; 80: ,,,,,. (ASCUS-LSIL). 1997; 40(2):

42 8.,,,. ASCUS, AGUS LSIL. 1997; 40: ,,,,,. Bethesda system "atypical squamous cells of undetermined significance". 1993; 4(20): Montz FJ, Bradley JM McCabe F et al. Natural history of minimally abnormal Papanicolaou smear. Obstet Gynecol 1992; 80: Jones HW III. Impact of the Bethesda system. Cancer 1995; 76(10Suppl): Williams ML, Rimm DL, Pedigo MA, Frable WJ. Histologic correlation of ASCUS: A university hospital s experience. Acta Cytol 1994; 38: Bowlin RB, Grillo D, Pittman KP, Lemos LB, Baliga M. Correlation of two ASCUS with cervical biopsy diagnoses: 492 cases from the Mississippi State Department of Health [abstract]. Acta Cytol 1996; 40: 1041A. 14. Terry RR. Management of patients with Atypical squamous cells of undetermined significance(ascus) on Papanicolaou smears. J Am Osteopath Assoc 1996; 96: Solomon D, Davey D, Kurman R, Moria rty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, Young N. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002 Apr 24; 287(16):

43 16. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ Consensus guidelines for the management of women with cervical cytological abnormalities.jama 2002 Apr. 24; 287(16): Brinton LA. Epidemiology of cervical cancer-overview, Munoz N. Bosch FX, Shah KV et al. eds. The epidemiology of cervic al cancer and Human Papillomavirus. Oxford, Oxford University Press 1992; Zur Hausen H. Papillomavirus in anogenital cancer as a model to understand the role of viruses in human cancer. Cancer Res 1989; 49: Lorincz AT, Reid R, Jenson AB, Greenberg MD, Lancaster W, Kurman RJ.Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol 1992 Mar;79(3): Lorincz AT, Temple GF, Kurman RJ, Jenson AB, Lancaster WD. Oncogenic association of specific human papillomavirus types with cervical neoplasia. J Natl Cancer Inst 1987 Oct; 79(4): Cuzick J, Sasieni P,Davies P,Adams J,Normand C, Frater A,Van Ballegoooijen M,van Den Akker E, A systematic review of the role of human paillomavirus testing within a cervical screening programme. Health Technol Assess 1999: 3(14): Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of 43

44 undetermined significance. Am J Obstet Gynecol 1995 Mar; 172(3): Apgar BS, Brotzman G. HPV testing in the evaluation of the minimally abnormal Papanicolaou smear. Am Fam Physician 1999 May 15; 59(10): Hatch KD, Schneider A, Abdel-Nour MW. An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy. Am J Obstet Gynecol 1995 Apr;172(4 Pt 1):1150-5; discussion Ferris DG, Wright TC Jr, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R. Triage of women with ASCUS and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy? J Fam Pract 1998 Feb; 46(2): Fait G, Kupferminc MJ, Daniel Y, Geva E, Ron IG, Lessing JB, Bar-Am A. Contribution of human papillomavirus testing by hybrid capture in the triage of women with repeated abnormal pap smears before colposcopy referral. Gynecol Oncol 2000 Nov; 79(2): Lorincz AT. Hybrid Capture method for detection of human papillomavirus DNA in clinical specimens: a tool for clinical management of equivocal Pap smears and for population screening. J Obstet Gynaecol Res 1996 Dec; 22(6): Wright TC, Sun XW, Koulos J. Comparison of management algorithms for the evaluation of women with low-grade cytologic abnormalities. Obstet 44

45 Gynecol 1995 Feb; 85(2): Sun XW, Ferenczy A, Johnson D et al. Evaluation of the Hybrid Capture human paillomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol 1995; 173: Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, van der Linden HC, Voorhorst FJ, Kenemans P, Meijer CJ Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999 Jul 3; 354(9172): Ronnett BM, Manos MM, Ransley JE, Fetterman BJ, Kinney WK, Hurley LB, Ngai JS, Kurman RJ, Sherman ME. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 1999 Jul; 30(7): Reid R, Greenberg MD, Lorincz A, Jenson AB, Laverty CR, Husain M, Daoud Y, Zado B, White T, Cantor D, et al. Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection? Am J Obstet Gynecol 1991 Jun; 164(6 Pt 1): ; discussion Ferenczy A. Viral testing for genital human papillomavirus infections: recent progress and clinical potentials. Int J Gynecol Cancer 1995 Sep; 5(5):

46 34.,,., : 3; Burke L. Cervicography: an alternative modality of cervical screening. Diagn Cytopathol 1991; 7(6):

The Korean Journal of Pathology 2011; 45: DOI: /KoreanJPathol ASC-H ํ™˜์ž์˜ p16 INK4a ๋ฉด์—ญ์„ธํฌํ™”ํ•™์—ผ์ƒ‰๊ฒ€์‚ฌ์˜์œ ์šฉ์„ฑ ์ž„๊ด‘์ผ ๊ฐ•์—ฌ์ฃผ ๊น€ํƒœ์€ ๋ฐ•๊ฒฝ์‹ ์ •์€์„  ์ตœ์˜์ง„ ์ด

The Korean Journal of Pathology 2011; 45: DOI: /KoreanJPathol ASC-H ํ™˜์ž์˜ p16 INK4a ๋ฉด์—ญ์„ธํฌํ™”ํ•™์—ผ์ƒ‰๊ฒ€์‚ฌ์˜์œ ์šฉ์„ฑ ์ž„๊ด‘์ผ ๊ฐ•์—ฌ์ฃผ ๊น€ํƒœ์€ ๋ฐ•๊ฒฝ์‹ ์ •์€์„  ์ตœ์˜์ง„ ์ด The Korean Journal of Pathology 2011; 45: 290-295 DOI: 10.4132/KoreanJPathol.2011.45.3.290 ASC-H ํ™˜์ž์˜ p16 INK4a ๋ฉด์—ญ์„ธํฌํ™”ํ•™์—ผ์ƒ‰๊ฒ€์‚ฌ์˜์œ ์šฉ์„ฑ ์ž„๊ด‘์ผ ๊ฐ•์—ฌ์ฃผ ๊น€ํƒœ์€ ๋ฐ•๊ฒฝ์‹ ์ •์€์„  ์ตœ์˜์ง„ ์ด๊ต์˜ ๊ฐ•์ฐฝ์„์ด์•„์› ๊ฐ€ํ†จ๋ฆญ๋Œ€ํ•™๊ต์˜๊ณผ๋Œ€ํ•™๋ณ‘์›๋ณ‘๋ฆฌํ•™๊ต์‹ค ์ ‘์ˆ˜ : 2011๋…„ 2์›” 28์ผ๊ฒŒ์žฌ์Šน์ธ :

More information

2009_254-259

2009_254-259 The Korean Journal of Pathology 2009; 43: 254-9 DOI: 10.4132/KoreanJPathol.2009.43.3.254 ASC-US ํ™˜์ž์—์„œ HPV DNA Microchip Test์˜ ์œ ์šฉ์„ฑ ๊ฒฝํฌ์€ ํ•˜์Šน์—ฐ ์ •๋™ํ•ด ๊น€๋‚˜๋ž˜ ๋ฐ•์ƒํฌ ์กฐํ˜„์ด ๊ฐ€์ฒœ์˜๋Œ€๊ธธ๋ณ‘์› ๋ณ‘๋ฆฌ๊ณผ ์ ‘ ์ˆ˜ : 2009๋…„ 3์›” 14์ผ ๊ฒŒ์žฌ์Šน์ธ : 2009๋…„ 5์›” 28์ผ

More information

2086

2086 ๋Œ€ํ•œ์ง„๋‹จ๊ฒ€์‚ฌ์˜ํ•™ํšŒ์ง€์ œ 28 ๊ถŒ์ œ 1 ํ˜ธ 2008 Korean J Lab Med 2008;28:70-8 DOI 10.3343/kjlm.2008.28.1.70 ์›์ € ์ง„๋‹จ์œ ์ „ํ•™ HPV ๋ฐฑ์‹ ์‹œ๋Œ€์— HPV DNA Chip ๊ฒ€์‚ฌ์˜์ž„์ƒํšจ์šฉ์„ฑ - 1,211์˜ˆ๋ถ„์„, ๋‹จ์ผ๊ธฐ๊ด€๋ณด๊ณ  - ๊ฐ•์ง€๋ฏผ 1 ์ดํฌ์ • 2 ๊ฐ€ํ†จ๋ฆญ๋Œ€ํ•™๊ต์˜๊ณผ๋Œ€ํ•™์ง„๋‹จ๊ฒ€์‚ฌ์˜ํ•™๊ต์‹ค 1, ๋ณ‘์›๋ณ‘๋ฆฌํ•™๊ต์‹ค 2 Clinical

More information

012์ž„์ˆ˜์ง„

012์ž„์ˆ˜์ง„ Received : 2012. 11. 27 Reviewed : 2012. 12. 10 Accepted : 2012. 12. 12 A Clinical Study on Effect of Electro-acupuncture Treatment for Low Back Pain and Radicular Pain in Patients Diagnosed with Lumbar

More information

untitled

untitled Ann Clin Microbiol Vol. 16, No. 2, June, 2013 http://dx.doi.org/10.5145/acm.2013.16.2.87 ISSN 2288-0585 Prevalence and Genotype of Human Papillomavirus Infection and Risk of Cervical Dysplasia among Asymptomatic

More information

๋ ˆ์ด์•„์›ƒ 1

๋ ˆ์ด์•„์›ƒ 1 ๋Œ€ํ•œ์œ„์žฅ๊ด€๊ธฐ์งˆ์ข…์–‘์—ฐ๊ตฌํšŒ 01 GIST 06 02 11 03 Imatinib 14 04 05 06 07 Sunitinib 32 40 44 48 GIST 6 01 7 GIST Guide book GIST 8 01 9 GIST Guide book GIST (CT) MRI FDG-PET 10 02 11 GIST Guide book 12 02 (Imatinib)

More information

ๆญฏ3์ผ_.PDF

ๆญฏ3์ผ_.PDF uuhm Daewoo Daily * 0.0% 23.6% 38.2% 50.0% 61.8% 100.0% 980 970 960 950 940 930 920 910 900 890 880 870 860 850 840 830 820 810 800 790 780 770 760 750 740 730 720 710 700 690 680 670 660 650 640 630

More information

๊น€๋ฒ”์ˆ˜

๊น€๋ฒ”์ˆ˜ Analysis of Outcomes after Resection of Sarcomatous Hepatocellular Carcinoma Purpose: Sarcomatous hepatocellular carcinoma (HCC) is rare. Therefore, the clinicopathologic characteristics and prognosis

More information

๋ชฉ ์ฐจ

๋ชฉ ์ฐจ ๋ชฉ ์ฐจ 1. ์ œํ’ˆ๋™ํ–ฅ Production < Demand and Supply of GI > Domestic Sales (Unit:10 3 ton) Inventory Import Export Apr 247.0 161.9 162.4 30.3 57.3 May 255.9 183.1 139.5 28.3 51.1 Jun 236.8 164.5 132.7 21.0 53.7

More information

Lumbar spine

Lumbar spine Lumbar spine CT 32 111 DOI : 10.3831/KPI.2010.13.2.111 Lumbar Spine CT 32 Received : 10. 05. 23 Revised : 10. 06. 04 Accepted : 10. 06. 11 Key Words: Disc herniation, CT scan, Clinical analysis The Clinical

More information

1..

1.. Volume 12, Number 1, 6~16, Factors influencing consultation time and waiting time of ambulatory patients in a tertiary teaching hospital Jee-In Hwang College of Nursing Science, Kyung Hee University :

More information

ํ™ฉ์ง€์›…

ํ™ฉ์ง€์›… Comparison of Laparoscopy and Exploration in the Distal Pancreatectomy BACKGROUND: To determine the benefits of laparoscopic surgery compared with exploration, the clinical outcomes of open and laparoscopic

More information

์ „๋ฆฝ์„ ์•”๋ฐœ์ƒ๋ฅ ์ถ”์ •๊ณผ๊ด€๋ จ์š”์ธ๋ถ„์„ : The Korean Cancer Prevention Study-II (KCPS-II)

์ „๋ฆฝ์„ ์•”๋ฐœ์ƒ๋ฅ ์ถ”์ •๊ณผ๊ด€๋ จ์š”์ธ๋ถ„์„ : The Korean Cancer Prevention Study-II (KCPS-II) ์ „๋ฆฝ์„ ์•”๋ฐœ์ƒ๋ฅ ์ถ”์ •๊ณผ๊ด€๋ จ์š”์ธ๋ถ„์„ : The Korean Cancer Prevention Study-II (KCPS-II) ์ „๋ฆฝ์„ ์•”๋ฐœ์ƒ๋ฅ ์ถ”์ •๊ณผ๊ด€๋ จ์š”์ธ๋ถ„์„ : The Korean Cancer Prevention Study-II (KCPS-II) - i - - ii - - iii - - iv - - v - - vi - - vii - - viii - - ix - -

More information

01kjc2008-29(์œคํ˜œ๊ฒฝ)636.qxp

01kjc2008-29(์œคํ˜œ๊ฒฝ)636.qxp ์ข…์„ค ๋Œ€ํ•œ์„ธํฌ๋ณ‘๋ฆฌํ•™ํšŒ์ง€ ISSN 1017-0391 10.3338/kjc.2008.19.2.65 ๋Œ€ํ•œ์„ธํฌ๋ณ‘๋ฆฌํ•™ํšŒ ์ •๋„๊ด€๋ฆฌ ํ˜„ํ™ฉ ๋ฐ ๊ฒฐ๊ณผ ์„์ง€๋Œ€ํ•™๊ต๋ณ‘์›, P&B ๋ณ‘๋ฆฌ๊ณผ์˜์›, 1 ์„œ์šธ์•„์‚ฐ๋ณ‘์›, 2 ์—ฌ์˜๋„์„ฑ๋ชจ๋ณ‘์›, 3 ๋ถ€์‚ฐ๋ฐฑ๋ณ‘์› 4 ๋ณ‘๋ฆฌ๊ณผ ์ดํ˜œ๊ฒฝ ๊น€ ์„ฑ๋‚จ 1 ๊ฐ• ์‹ ๊ด‘ 2 ๊ฐ• ์ฐฝ์„ 3 ์œค ํ˜œ๊ฒฝ 4 Quality Control Program and Its Results

More information

IR์ปฌ๋Ÿผ ์ฐฉ์‹œํ˜„์ƒ ๋•Œ๋ฌธ์ด๋ผ๊ณ  ํ•  ์ˆ˜ ์žˆ๋‹ค. KOSPI ์ง€์ˆ˜์˜ ๋ณ€ํ™” ์œจ์ด๋‚˜ KOSPI ์ง€์ˆ˜ ๋Œ€๋น„ ์ƒ๋Œ€์ ์ธ ๋ณ€๋™ํญ์œผ๋กœ ์ธก์ •ํ•œ ์ตœ๊ทผ ์šฐ๋ฆฌ๋‚˜๋ผ ์ฃผ์‹์‹œ์žฅ์˜ ์ฃผ๊ฐ€๋ณ€๋™์„ฑ์€ 1980๋…„ ์ดํ›„ ์ตœ์ € ์ˆ˜์ค€์— ๊ทผ์ ‘ํ•œ ์ •๋„๋กœ ๋‚ฎ์•„์กŒ๋‹ค. ์šฐ๋ฆฌ๋‚˜๋ผ ์ฃผ๊ฐ€๋ณ€๋™์„ฑ, ๊ธ€๋กœ๋ฒŒ ์‹œ์žฅ๋ณด๋‹ค ๋น ๋ฅด ๊ฒŒ ๊ฐ์†Œ 19

IR์ปฌ๋Ÿผ ์ฐฉ์‹œํ˜„์ƒ ๋•Œ๋ฌธ์ด๋ผ๊ณ  ํ•  ์ˆ˜ ์žˆ๋‹ค. KOSPI ์ง€์ˆ˜์˜ ๋ณ€ํ™” ์œจ์ด๋‚˜ KOSPI ์ง€์ˆ˜ ๋Œ€๋น„ ์ƒ๋Œ€์ ์ธ ๋ณ€๋™ํญ์œผ๋กœ ์ธก์ •ํ•œ ์ตœ๊ทผ ์šฐ๋ฆฌ๋‚˜๋ผ ์ฃผ์‹์‹œ์žฅ์˜ ์ฃผ๊ฐ€๋ณ€๋™์„ฑ์€ 1980๋…„ ์ดํ›„ ์ตœ์ € ์ˆ˜์ค€์— ๊ทผ์ ‘ํ•œ ์ •๋„๋กœ ๋‚ฎ์•„์กŒ๋‹ค. ์šฐ๋ฆฌ๋‚˜๋ผ ์ฃผ๊ฐ€๋ณ€๋™์„ฑ, ๊ธ€๋กœ๋ฒŒ ์‹œ์žฅ๋ณด๋‹ค ๋น ๋ฅด ๊ฒŒ ๊ฐ์†Œ 19 2016. 2 ํ†ต๊ถŒ ์ œ185ํ˜ธ ๋ฐœํ–‰์ผ : 2016๋…„ 2์›” 1์ผ / ๋ฐœํ–‰์ธ : ์ดํ˜ธ์ฒ  / ํŽธ์ง‘์ธ : ๊ฐ•ํ™๊ธฐ / ๋ฐœํ–‰์ฒ˜ : ํ•œ๊ตญIRํ˜‘์˜ํšŒ / TEL 02-6922-5000 / ์ œ์ž‘์ฒ˜ : ํ•œ์•„๋ฆ„์ธ์‡„ โ… Contentsโ…  IR์ปฌ๋Ÿผ 01 _ IR์ปฌ๋Ÿผ ๋ณ€๋™์„ฑ ์ปธ๋˜ ํ•œ๊ตญ ์ฃผ์‹์‹œ์žฅ, ์ €์œ„ํ—˜ ์ €์ˆ˜์ต ์‹œ์žฅ์œผ๋กœ 03 _ CEO์ธํ„ฐ๋ทฐ ๋ณ€๋™์„ฑ ์ปธ๋˜ ํ•œ๊ตญ ์ฃผ์‹์‹œ์žฅ, ์ €์œ„ํ—˜ ์ €์ˆ˜์ต ์‹œ์žฅ์œผ๋กœ

More information

Sheu HM, et al., British J Dermatol 1997; 136: Kao JS, et al., J Invest Dermatol 2003; 120:

Sheu HM, et al., British J Dermatol 1997; 136: Kao JS, et al., J Invest Dermatol 2003; 120: Sheu HM, et al., British J Dermatol 1997; 136:884-890 Kao JS, et al., J Invest Dermatol 03; 1:446-464 1 10 0 3 Day Normal MLE Lotion Lotion MLE Cream Cream 80 7 70 6 3 Day Normal MLE Lotion Lotion MLE

More information

wkrndrudqn ์ƒํ”ผ๋‚ด ์ดํ˜•์„ฑ์ฆ

wkrndrudqn ์ƒํ”ผ๋‚ด ์ดํ˜•์„ฑ์ฆ ์ˆœ์ฒœํ–ฅ์˜๋Œ€๋…ผ๋ฌธ์ง‘ : ์ œ 14 ๊ถŒ 1 ํ˜ธ 2008 J. Soonchunhyang Med. Coll. 14(1), p143-147, 2008 ์ž๊ถ๊ฒฝ๋ถ€์„ธํฌ์ดํ˜•์„ฑ์ฆ์—๋Œ€ํ•œ Ureaplasma urealyticum ๋ฐ Mycoplasma hominis ๊ฐ์—ผ์˜๋ณ‘์ธ์ ์กฐ์ธ์ž๋กœ์„œ์˜์˜์˜์—๋Œ€ํ•œ์—ฐ๊ตฌ์ˆœ์ฒœํ–ฅ๋Œ€ํ•™๊ต์˜๊ณผ๋Œ€ํ•™์‚ฐ๋ถ€์ธ๊ณผํ•™๊ต์‹ค ๋ฐ•ํ˜œ์—ฐใ†๊น€๋ฏธ๊ฒฝใ†์ฐจ์ƒํ—Œใ†์ตœ๊ทœ์—ฐใ†์ด์ •์žฌใ†์ด์ž„์ˆœ Ureaplasma

More information

Microsoft Word - retail_131122.doc

Microsoft Word - retail_131122.doc Analyst ์œ ์ฃผ์—ฐ (639-4584) juyeon.yu@meritz.co.kr RA ๋ฐ•์ง€์€ (639-451) jeeeun.park@meritz.co.kr 213.11.22 ์œ ํ†ต์—… Overweight 1์›” ๋งค์ถœ๋™ํ–ฅ: ๋Œ€ํ˜•๋งˆํŠธ -6.4%, ๋ฐฑํ™”์  -2.2% Top Pick ํ•˜์ด๋งˆํŠธ (7184) Buy, TP 15,์› ํ˜„๋Œ€ํ™ˆ์‡ผํ•‘ (575) Buy, TP 21,์›

More information

Microsoft Word - 20150811201049900_1

Microsoft Word - 20150811201049900_1 Company Report 215.8.12 CJ E&M (1396) ๊ธฐ๋Œ€๋ณด๋‹ค ์ข‹์•˜๊ณ  ์•ž์œผ๋กœ๋„ ์ข‹์„ ๋“ฏ ๋ฏธ๋””์–ด/์—”ํ„ฐ What s new? Our view ํˆฌ์ž์˜๊ฒฌ: BUY (M) ๋ชฉํ‘œ์ฃผ๊ฐ€: 12,์› (M) ์ฃผ๊ฐ€ (8/11) 81,5์› ์ž๋ณธ๊ธˆ ์‹œ๊ฐ€์ด์•ก 1,937์–ต์› 31,567์–ต์› ์ฃผ๋‹น์ˆœ์ž์‚ฐ 42,468์› ๋ถ€์ฑ„๋น„์œจ 49.26% ์ด๋ฐœํ–‰์ฃผ์‹์ˆ˜ 6์ผ ํ‰๊ท  ๊ฑฐ๋ž˜๋Œ€๊ธˆ 38,732,89์ฃผ

More information

Microsoft Word - 20121030140354943_0.doc

Microsoft Word - 20121030140354943_0.doc Sector Report 212.11.14 ํ†ต์‹ ์„œ๋น„์Šค 213๋…„ ํ†ต์‹  ์ „๋ง: LTE์˜ ๊ฒฐ์‹ค์„ ์ˆ˜ํ™•ํ•˜๋Š” ํ•ด ํ†ต์‹ /ํœด๋Œ€ํฐ Analyst ์ตœ๋‚จ๊ณค 2-377-3549 Research Associate ๊น€ ์†” 2-377-3496 213๋…„์˜ ํ™”๋‘๋Š” LTE์˜ ์ˆ˜์ตํ™”, ๋‰ด๋ฏธ๋””์–ด์˜ ํ™•์žฅ ์ง€์† ๋“ฑ์œผ๋กœ ์ „๋ง๋ฉ๋‹ˆ๋‹ค. ์ƒ๋Œ€์ ์œผ๋กœ ๋น„์ค‘์„ ๋Š˜๋ ค์•ผ ํ•  ์ข…๋ชฉ์€ LTE์—์„œ ์ข‹์€ ์„ฑ๊ณผ๋ฅผ ๋ณด์ด๊ณ 

More information

K O R E A C E N T E R S F O R D I S E A S E C O N T R O L & P R E V E N T I O N PHWR Vol. 5 No. 41 www.cdc.go.kr/phwr 2012 10 12 5 41 ISSN:2005-811X Comparison of drug-susceptibility test to the anti-tuberculosis

More information

April. 28, 216 Fixed Income Analyst 2 3 2. 1.5 (%) (%).1.5. (%) (%) 1. 1 y 2 y 3 y 4 y 5 y 7 y 1 1 1 2 -.5 2.5 2.2 (%) 1y 3y 5y 1y (%) 1.9 1.6 1.3 1. '15Y.8 '15Y.12 '16Y.4 (%) (%) () Apr. 28, 216

More information

ํ•œ๊ตญ์„ฑ์ธ์—์„œ์ดˆ๊ธฐํ™ฉ๋ฐ˜๋ณ€์„ฑ์งˆํ™˜๊ณผ ์—ฐ๊ด€๋œ์œ„ํ—˜์š”์ธ์—ฐ๊ตฌ

ํ•œ๊ตญ์„ฑ์ธ์—์„œ์ดˆ๊ธฐํ™ฉ๋ฐ˜๋ณ€์„ฑ์งˆํ™˜๊ณผ ์—ฐ๊ด€๋œ์œ„ํ—˜์š”์ธ์—ฐ๊ตฌ ํ•œ๊ตญ์„ฑ์ธ์—์„œ์ดˆ๊ธฐํ™ฉ๋ฐ˜๋ณ€์„ฑ์งˆํ™˜๊ณผ ์—ฐ๊ด€๋œ์œ„ํ—˜์š”์ธ์—ฐ๊ตฌ ํ•œ๊ตญ์„ฑ์ธ์—์„œ์ดˆ๊ธฐํ™ฉ๋ฐ˜๋ณ€์„ฑ์งˆํ™˜๊ณผ ์—ฐ๊ด€๋œ์œ„ํ—˜์š”์ธ์—ฐ๊ตฌ - - i - - i - - ii - - iii - - iv - ฯ‡ - v - - vi - - 1 - - 2 - - 3 - - 4 - ๊ทธ๋ฆผ 1. ์—ฐ๊ตฌ๋Œ€์ƒ์ž์„ ์ •๋„ํ‘œ - 5 - - 6 - - 7 - - 8 - ๊ทธ๋ฆผ 2. ์—ฐ๊ตฌ์˜ํ‹€ ฯ‡ - 9 - - 10 - - 11 -

More information

Jan. 27, 216 Fixed Income Analyst 1,,,, BOK 216-2, : Pass-Through of Imported Input Prices to Deomestic Producer Prices: Evidence from Sector- Level Data 2 215-53, 2p, : Alexander Chudik and Janet

More information

๋‹ฌ์ƒ์‚ฐ์ด ์ดˆ์‚ฐ๋ชจ ๋ถ„๋งŒ์‹œ๊ฐ„์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ โ… . ์„œ ๋ก  โ…ก. ์—ฐ๊ตฌ๋Œ€์ƒ ๋ฐ ๋ฐฉ๋ฒ• ้” ์€ 23) ์˜ ไธน ๆบช ์— ์ตœ์ดˆ๋กœ ๊ธฐ ์žฌ๋œ ์ฒ˜๋ฐฉ์œผ๋กœ, ์— ๋ณต์šฉํ•˜๋ฉด ํ•œ ๋‹คํ•˜์—ฌ ๋‚œ์‚ฐ์˜ ์˜ˆ๋ฐฉ๊ณผ ๋ฐ, ๋“ฑ์— ๋„๋ฆฌ ํ™œ์šฉ๋˜์–ด ์™”๋‹ค. ้” ์€ ์ด ๆฏ’ ํ•˜๊ณ  ๋Š” ็”˜ ่‹ฆ ํ•˜์—ฌ ๆฐฃ, ๆฐฃ ๅฏฌ,, ็ต ์˜ ํšจ๋Šฅ์ด ์žˆ

๋‹ฌ์ƒ์‚ฐ์ด ์ดˆ์‚ฐ๋ชจ ๋ถ„๋งŒ์‹œ๊ฐ„์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ โ… . ์„œ ๋ก  โ…ก. ์—ฐ๊ตฌ๋Œ€์ƒ ๋ฐ ๋ฐฉ๋ฒ• ้” ์€ 23) ์˜ ไธน ๆบช ์— ์ตœ์ดˆ๋กœ ๊ธฐ ์žฌ๋œ ์ฒ˜๋ฐฉ์œผ๋กœ, ์— ๋ณต์šฉํ•˜๋ฉด ํ•œ ๋‹คํ•˜์—ฌ ๋‚œ์‚ฐ์˜ ์˜ˆ๋ฐฉ๊ณผ ๋ฐ, ๋“ฑ์— ๋„๋ฆฌ ํ™œ์šฉ๋˜์–ด ์™”๋‹ค. ้” ์€ ์ด ๆฏ’ ํ•˜๊ณ  ๋Š” ็”˜ ่‹ฆ ํ•˜์—ฌ ๆฐฃ, ๆฐฃ ๅฏฌ,, ็ต ์˜ ํšจ๋Šฅ์ด ์žˆ ๋Œ€ํ•œํ•œ๋ฐฉ๋ถ€์ธ๊ณผํ•™ํšŒ์ง€ THE JOURNAL OF ORIENTAL OBSTETRICS & GYNECOLOGY VOL.17, NO.2 : 115-122 (2004) ๋‹ฌ์ƒ์‚ฐ์ด ์ดˆ์‚ฐ๋ชจ ๋ถ„๋งŒ์‹œ๊ฐ„์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ * ๋ถ๊ฒฝํ•œ์˜์›, ** ์œค์‚ฐ๋ถ€์ธ๊ณผ์˜์›, *** ์ตœ์€๋ฆผ์‚ฐ๋ถ€์ธ๊ณผ์˜์›, ์ƒ์ง€๋Œ€ํ•™๊ต ํ•œ์˜๊ณผ๋Œ€ํ•™ ๋ถ€์ธ๊ณผํ•™๊ต์‹ค ****, ๊ฒฝํฌ๋Œ€ํ•™๊ต ๋™์„œ์˜ํ•™๋Œ€ํ•™์› ๊น€์„ฑ์ค€ *****, ์œค์™•์ค€

More information

untitled

untitled 132 Mi Hee Sung, et al. p16 INK4a /Ki-67 Dual Immunostaining in Liquid-based Cytology ORIGINAL ARTICLE Korean J Clin Lab Sci. 2015, 47(3):132-139 http://dx.doi.org/10.15324/kjcls.2015.47.3.132 pissn 1738-3544

More information

์ฃผ๊ฐ„๊ฑด๊ฐ•๊ณผ์งˆ๋ณ‘ ์ œ 8 ๊ถŒ์ œ 34 ํ˜ธ ์ธ์œ ๋‘์ข…๋ฐ”์ด๋Ÿฌ์Šค DNA ๊ฒ€์‚ฌ์ •๋„ํ‰๊ฐ€์†Œ๊ฐœ Introduction of Human Papillomavirus (HPV) DNA Proficiency Testing Programs Abstract Cervical cancer is the

์ฃผ๊ฐ„๊ฑด๊ฐ•๊ณผ์งˆ๋ณ‘ ์ œ 8 ๊ถŒ์ œ 34 ํ˜ธ ์ธ์œ ๋‘์ข…๋ฐ”์ด๋Ÿฌ์Šค DNA ๊ฒ€์‚ฌ์ •๋„ํ‰๊ฐ€์†Œ๊ฐœ Introduction of Human Papillomavirus (HPV) DNA Proficiency Testing Programs Abstract Cervical cancer is the ์ธ์œ ๋‘์ข…๋ฐ”์ด๋Ÿฌ์Šค DNA ๊ฒ€์‚ฌ์ •๋„ํ‰๊ฐ€์†Œ๊ฐœ Introduction of Human Papillomavirus (HPV) DNA Proficiency Testing Programs Abstract Cervical cancer is the second most common type of cancer among women worldwide and Human Papilloma

More information

๋…ธ์˜๋‚จ

๋…ธ์˜๋‚จ Purpose: Delayed massive hemorrhages from pseudoaneurysm rupture of the peripancreatic large arteries, after pancreaticoduodenectomy, are fatal. We reviewed the clinical course and outcome of bleeding

More information

, Analyst, , Figure 1 ํ†ต์‹ ์‚ฌ๊ฐ€์ž…์ž์ถ”์ด ( ๋ช…, 000) 60,000 LG U+ KT SKT 50,000 40,000 30,000 20,000 10,000 0 ์ž๋ฃŒ : MSIP. ๋ฏธ๋ž˜์—์…‹์ฆ๊ถŒ๋ฆฌ์„œ์น˜์„ผํ„ฐ

, Analyst, , Figure 1 ํ†ต์‹ ์‚ฌ๊ฐ€์ž…์ž์ถ”์ด ( ๋ช…, 000) 60,000 LG U+ KT SKT 50,000 40,000 30,000 20,000 10,000 0 ์ž๋ฃŒ : MSIP. ๋ฏธ๋ž˜์—์…‹์ฆ๊ถŒ๋ฆฌ์„œ์น˜์„ผํ„ฐ Earnings preview, Target price lowered Korea / Telecommunication&Utilities 7 July 2016 OVERWEIGHT Stocks under coverage Company Rating Price Target price Target price change Previous New, Analyst 3774

More information

ยตรฐร‡รƒร‡ยฅรรถยฑยคยฐรญยดรœยธรฉ

ยตรฐร‡รƒร‡ยฅรรถยฑยคยฐรญยดรœยธรฉ 2013. JAN. FEB. VOL.23 2013. JAN. FEB. VOL.23 Review Preview Company Technical Point Focus Issue Market Trend Industrial Trend Policy Report KDIA News Tour Statistics KDIA 02 10 11 12 15 16 22 28 36 38

More information

<3034B0EDC0E7BCF62E717870>

<3034B0EDC0E7BCF62E717870> ๋Œ€ํ•œ์„ธํฌ๋ณ‘๋ฆฌํ•™ํšŒ์ง€ ISSN 1017-0391 ์ž๊ถ๊ฒฝ๋ถ€, ์ฒด์•ก๋ฐ์†Œ๋ณ€์˜ํƒˆ๋ฝ์„ธํฌ์ง„๊ฒ€์‚ฌ์—์„œ CellPrep ์•ก์ƒ์„ธํฌ๊ฒ€์‚ฌ์˜์„ธํฌํ•™์ ํ‰๊ฐ€ -ThinPrep ๊ณผ๋น„๊ต๋ถ„์„ - ์›์ž๋ ฅ๋ณ‘์›๋ณ‘๋ฆฌ๊ณผ ๊ณ ์žฌ์ˆ˜ ์กฐ์ˆ˜์—ฐ ํ•˜ํ™”์ • ๊น€์ •์ˆœ ์‹ ๋ช…์ˆœ Cytologic Evaluation of CellPrep Liquid-based Cytology in Cervicovaginal, Body Fluid,

More information

๊ธฐ๊ด€๊ณ ์œ ์—ฐ๊ตฌ์‚ฌ์—…๊ฒฐ๊ณผ๋ณด๊ณ 

๊ธฐ๊ด€๊ณ ์œ ์—ฐ๊ตฌ์‚ฌ์—…๊ฒฐ๊ณผ๋ณด๊ณ  ๊ธฐ๊ด€๊ณ ์œ ์—ฐ๊ตฌ์‚ฌ์—…๊ฒฐ๊ณผ๋ณด๊ณ  ์ž‘์„ฑ์š”๋ น 2001 ~ 2004 2005 ~ 2007 2008 ~ 2010 2001 ~ 2004 2005 ~ 2007 2008 ~ 2010 1 2/3 2 1 0 2 3 52 0 31 83 12 6 3 21 593 404 304 1,301 4 3 1 8 159 191 116 466 6 11 (`1: (1: 16 33 44 106

More information

Abstract Musculoskeletal Symptoms and Related Factors for Nurses and Radiological Technologists Wearing a Lead Apron for Radiation Pro t e c t i o n Jung-Im Yoo, Jung-Wan Koo 1 ) Angio Unit, Team of Radiology,

More information

Microsoft Word - IO_2009_๋ฉ”๋ชจ๋ฆฌ๋ฐ˜๋„์ฒด.doc

Microsoft Word - IO_2009_๋ฉ”๋ชจ๋ฆฌ๋ฐ˜๋„์ฒด.doc ๋ฉ”๋ชจ๋ฆฌ ๋ฐ˜๋„์ฒด SemiconductorMemory Chips 2009.1 ํ‰๊ฐ€1์‹ค ์กฐ์ˆ˜ํฌ ์• ๋„๋ฆฌ์ŠคํŠธ 7872321 suhee.cho@kisrating.com ํ‰๊ฐ€1์‹ค ๋ฐ•์ถ˜์„ฑ ์—ฐ๊ตฌ์œ„์› 7872341 cspark@kisrating.com ํ‰๊ฐ€1์‹ค ์†์žฌํ˜• ์‹ค์žฅ 7872250 jaihyoung.son@kisrating.com Summary ๊ณต๊ธ‰๊ณผ์ž‰ ์ƒํƒœ๊ฐ€ ์ง€์†๋˜๋Š”

More information

์„œ๋ก  34 2

์„œ๋ก  34 2 34 2 Journal of the Korean Society of Health Information and Health Statistics Volume 34, Number 2, 2009, pp. 165 176 165 ์ง„์€ํฌ A Study on Health related Action Rates of Dietary Guidelines and Pattern of

More information

Can032.hwp

Can032.hwp Chromosomal Alterations in Hepatocellular Carcinoma Cell Lines Detected by Comparative Genomic Hybridization Sang Jin Park 1, Mahn Joon Ha, Ph.D. 1, Hugh Chul Kim, M.D. 2 and Hyon Ju Kim, M.D. 1 1 Laboratory

More information

Abstract Background : Most hospitalized children will experience physical pain as well as psychological distress. Painful procedure can increase anxie

Abstract Background : Most hospitalized children will experience physical pain as well as psychological distress. Painful procedure can increase anxie Volume 12, Number 1, 92~102, An Intervention Study of Pain Reduction during IV Therapy in Hospitalized Children Myo-Jin Kim 1), Joung-Hae Bak 1), Won-Seok Seo 2) Mi-Young Kim 3), Sun-Kyoung Park 3), Jai-Soung

More information

<BFF8C0FA2DC1A4BFB5C1D628C1B6B5BFC8DE29283431307E343135292E687770>

<BFF8C0FA2DC1A4BFB5C1D628C1B6B5BFC8DE29283431307E343135292E687770> Korean Journal of Obstetrics and Gynecology Vol. 53 No. 5 May 2010 ๋ณด๊ฑด์ง ์—ฌ์„ฑ๊ณต๋ฌด์›์˜ ์ธ์œ ๋‘์ข…๋ฐ”์ด๋Ÿฌ์Šค ๊ฐ์—ผ์— ๋Œ€ํ•œ ์ธ์‹ ๋ฐ ์ง€์‹์กฐ์‚ฌ ์ „๋ถ๋Œ€ํ•™๊ต ์˜ํ•™์ „๋ฌธ๋Œ€ํ•™์› ์‚ฐ๋ถ€์ธ๊ณผํ•™๊ต์‹ค 1, ์˜๊ณผํ•™์—ฐ๊ตฌ์†Œ 2 ์กฐ๋™ํœด 1 ๊น€์€๊ฒฝ 1 ์ด๋™ํ˜„ 1 ์ตœ์›๊ตฌ 1 ์ž„์€์ง€ 1 ๊น€์ข…ํ˜„ 1,2 ์ด์ •ํ—Œ 1,2 ์กฐ์„ฑ๋‚จ 1,2 ์˜ค๋ณ‘์ฐฌ 1,2 ์ •์˜์ฃผ

More information

14.531~539(08-037).fm

14.531~539(08-037).fm G Journal of the Korea Concrete Institute Vol. 20, No. 4, pp. 531~539, August, 2008 ลก x y w m ลก gj p { sฦ’ z 1) * 1) w w Evaluation of Flexural Strength for Normal and High Strength Concrete with Hooked

More information

2009ยฝร…ยฟรซร†รฒยฐยก-ยณยปรรถ0209รƒร–รยพ

2009ยฝร…ยฟรซร†รฒยฐยก-ยณยปรรถ0209รƒร–รยพ 10 11 Special Report PC CD DVD TV PDA 12 13 Special Report 1 MMORPG NC NC 2 FPS CJ 3 4 MMORPG 5 MMORPG 6 2 7 MMORPG NC NC 8 NHN NHN 9 MMORPG 10 14 15 Special Report 2004 11 ( ) 28.96% 960 2005 6 3.52%

More information

..........5-45..

..........5-45.. K O R E A C E N T E R S F O R D I S E A S E C O N T R O L & P R E V E N T I O N PHWR Vol. 5 No. 45 www.cdc.go.kr 2012 11 9 5 45 ISSN:2005-811X Monitoring of antimicrobial resistance on non-tertiary hospitals

More information

์ฑ…์ž„์—ฐ๊ตฌ๊ธฐ๊ด€

์ฑ…์ž„์—ฐ๊ตฌ๊ธฐ๊ด€ 2009. 2. ์ฑ…์ž„์—ฐ๊ตฌ๊ธฐ๊ด€ - i - - ii - - iii - - iv - 6.3.1 Sample Collection and Analysis 161 6.3.1.1 Sample Collection 161 6.3.1.2 Sample Analysis 161 6.3.2 Results 162 6.3.2.1 Dalian 162 6.3.2.2 Xiamen 163 6.3.3

More information

12์ด๋ฌธ๊ทœ

12์ด๋ฌธ๊ทœ Review on Conservative Treatment of Spinal Scoliosis Moon-kyu Lee, O.M.D., Gil-jae Lee, O.M.D., Yun-kyung Song, O.M.D., Hyung-ho Lim, O.M.D. Dept. of Oriental Rehabilitation Medicine College of Oriental

More information

Kbcs002.hwp

Kbcs002.hwp Does Real-time Compound Imaging Improve Evaluation of reast Cancer Compared to Conventional Sonography? o Kyoung Seo, M.D., Yu Whan Oh, M.D., Kyu Ran Cho, M.D., Young Hen Lee, M.D., Hyung Joon Noh, M.D.,

More information

l l l l l l l l l Lee, Geon Kook None This project was designed to establish the Tumor Bank of National Cancer Center in 2000. From the first tumor sample in 2000, the total of tumor and tumor-related

More information

- i - - ii - - iii - - iv - - v - - 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - - 15 - - 16 - - 17 - - 18 - - 19 - ฮฑ ฮฑ - 20 - ฮฑ ฮฑ ฮฑ ฮฑ ฮฑ ฮฑ - 21 - - 22 - - 23 -

More information

์ง€์›์—ฐ๊ตฌ๋ถ„์•ผ ( ์ฝ”๋“œ ) LC0202 ๊ณผ์ œ๋ฒˆํ˜ธ ์ฐฝ์˜๊ณผ์ œํ”„๋กœ๊ทธ๋žจ๊ณต๊ฐœ๊ฐ€๋Šฅ์—ฌ๋ถ€๊ณผ์ œ์„ฑ๊ฒฉ ( ๊ธฐ์ดˆ, ์‘์šฉ, ๊ฐœ๋ฐœ ) ์‘์šฉ์‹ค์šฉํ™”๋Œ€์ƒ์—ฌ๋ถ€์‹ค์šฉํ™”๊ณต๊ฐœ ( ๊ณต๊ฐœ, ๋น„๊ณต๊ฐœ ) ( ๊ตญ๋ฌธ ) ์—ฐ๊ตฌ๊ณผ์ œ๋ช… ๊ณผ์ œ์ฑ…์ž„์ž ์„ธ๋ถ€๊ณผ์ œ ( ์˜๋ฌธ ) ๊ตฌ๋ถ„ ์†Œ์†์œ„์•”์—ฐ๊ตฌ๊ณผ์ง์œ„์ฑ…์ž„์—ฐ๊ตฌ์›

์ง€์›์—ฐ๊ตฌ๋ถ„์•ผ ( ์ฝ”๋“œ ) LC0202 ๊ณผ์ œ๋ฒˆํ˜ธ ์ฐฝ์˜๊ณผ์ œํ”„๋กœ๊ทธ๋žจ๊ณต๊ฐœ๊ฐ€๋Šฅ์—ฌ๋ถ€๊ณผ์ œ์„ฑ๊ฒฉ ( ๊ธฐ์ดˆ, ์‘์šฉ, ๊ฐœ๋ฐœ ) ์‘์šฉ์‹ค์šฉํ™”๋Œ€์ƒ์—ฌ๋ถ€์‹ค์šฉํ™”๊ณต๊ฐœ ( ๊ณต๊ฐœ, ๋น„๊ณต๊ฐœ ) ( ๊ตญ๋ฌธ ) ์—ฐ๊ตฌ๊ณผ์ œ๋ช… ๊ณผ์ œ์ฑ…์ž„์ž ์„ธ๋ถ€๊ณผ์ œ ( ์˜๋ฌธ ) ๊ตฌ๋ถ„ ์†Œ์†์œ„์•”์—ฐ๊ตฌ๊ณผ์ง์œ„์ฑ…์ž„์—ฐ๊ตฌ์› ์ง€์›์—ฐ๊ตฌ๋ถ„์•ผ ( ์ฝ”๋“œ ) LC0202 ๊ณผ์ œ๋ฒˆํ˜ธ 1110550 ์ฐฝ์˜๊ณผ์ œํ”„๋กœ๊ทธ๋žจ๊ณต๊ฐœ๊ฐ€๋Šฅ์—ฌ๋ถ€๊ณผ์ œ์„ฑ๊ฒฉ ( ๊ธฐ์ดˆ, ์‘์šฉ, ๊ฐœ๋ฐœ ) ์‘์šฉ์‹ค์šฉํ™”๋Œ€์ƒ์—ฌ๋ถ€์‹ค์šฉํ™”๊ณต๊ฐœ ( ๊ณต๊ฐœ, ๋น„๊ณต๊ฐœ ) ( ๊ตญ๋ฌธ ) ์—ฐ๊ตฌ๊ณผ์ œ๋ช… ๊ณผ์ œ์ฑ…์ž„์ž ์„ธ๋ถ€๊ณผ์ œ ( ์˜๋ฌธ ) ๊ตฌ๋ถ„ 1 2 3 ์†Œ์†์œ„์•”์—ฐ๊ตฌ๊ณผ์ง์œ„์ฑ…์ž„์—ฐ๊ตฌ์› ์„ฑ๋ช…๋ฅ˜๊ทผ์›์ „๊ณต์™ธ๊ณผ ์„ธ๋ถ€๊ณผ์ œ๋ช… ์„ธ๋ถ€๊ณผ์ œ์ฑ…์ž„์ž ์„ฑ๋ช… ์†Œ์† ( ์ง์œ„ ) ์ „๊ณต ์ด์—ฐ๊ตฌ๊ธฐ๊ฐ„ 2011

More information

2011ยดรซร‡รยฟรธ2ยตยต 24p_0628

2011ยดรซร‡รยฟรธ2ยตยต 24p_0628 2011 Guide for U.S. Graduate School Admissions Table of Contents 02 03 04 05 06 08 09 10 11 13 15 21 LEADERS UHAK INTERNATIONAL STUDENTS SERVICE www.leadersuhak.com Leaders Uhak International Students

More information

์„์‚ฌ๋…ผ๋ฌธ.PDF

์„์‚ฌ๋…ผ๋ฌธ.PDF ABO Rh A study on the importance of ABO and Rh blood groups information in Public Health 2000 2 1 ABO Rh A study on the importance of ABO and Rh blood groups information in Public Health 2000 2 2 ABO Rh

More information

๋ ˆ์ด์•„์›ƒ 1

๋ ˆ์ด์•„์›ƒ 1 i g d e d mod, t d e d e d mod, t e,0 e, n s,0 e,n e,0 Division of Workers' Compensation (2009). Iowa workers' compensation manual. Gamber, E. N. & Sorensen, R. L. (1994). Are net discount rates stationary?:

More information

.......... ...... 28.. ....

.......... ...... 28.. .... Industrial Trend Industrial Trend > Part. Set (2013.10.30) 24 2013 NOV DEC. vol. 28 (2013.11.05) (2013.11.15) Display Focus 25 Industrial Trend (2013.11.22) 26 2013 NOV DEC. vol. 28 (2013.11.28) (2013.11.25)

More information

.,,,,,,.,,,,.,,,,,, (, 2011)..,,, (, 2009)., (, 2000;, 1993;,,, 1994;, 1995), () 65, 4 51, (,, ). 33, 4 30, (, 201

.,,,,,,.,,,,.,,,,,, (, 2011)..,,, (, 2009)., (, 2000;, 1993;,,, 1994;, 1995), () 65, 4 51, (,, ). 33, 4 30, (, 201 4 21.,,,.,,. 1, 2, 3, 4.,,,,,,.,,,,., ( ). 60-66,,,,,.. (Corresponding Author): / / 303 Tel: 063-220-2495/ E-mail: ikkim@jj.ac.kr .,,,,,,.,,,,.,,,,,, (, 2011)..,,, (, 2009)., (, 2000;, 1993;,,, 1994;,

More information

ยฑรจร‡ยฅยณรข

ยฑรจร‡ยฅยณรข 533 Fig. 1. Dead zone. Nine echoes are positioned 2-10 mm below the scan surface with 1 mm distance. All nine echoes are clearly visualized. 534 Fig. 2. Vertical and horizontal measurement. 10 cm distance

More information

ๆญฏ์ž๋ฃŒ

ๆญฏ์ž๋ฃŒ To Shareholders & Investors KTF 21 Contents 1 KTF+KTM ( : ) FY21 FY2 (%) I. 789,14 142,62 453.4% 1. PCS 3,986,78 3,271,77 21.8% PCS 2,91,193 2,349,386 23.5% 941,6 873,57 7.8% 111,665 29,191 282.5% 31,62

More information

(Exposure) Exposure (Exposure Assesment) EMF Unknown to mechanism Health Effect (Effect) Unknown to mechanism Behavior pattern (Micro- Environment) Re

(Exposure) Exposure (Exposure Assesment) EMF Unknown to mechanism Health Effect (Effect) Unknown to mechanism Behavior pattern (Micro- Environment) Re EMF Health Effect 2003 10 20 21-29 2-10 - - ( ) area spot measurement - - 1 (Exposure) Exposure (Exposure Assesment) EMF Unknown to mechanism Health Effect (Effect) Unknown to mechanism Behavior pattern

More information

<38BFF93238C0CF28B1DDBFE4C0CF2920BFB9BBF3B9E8B4E72E786C7378>

<38BFF93238C0CF28B1DDBFE4C0CF2920BFB9BBF3B9E8B4E72E786C7378> [๋ถ€์‚ฐ ] 2009๋…„ 08์›” 28์ผ ( ๏คŠ ) 1๊ฒฝ์ฃผ ๊ตญ 5(๋งˆ๋ น)1000M ๋ฐœ์ฃผ 13:00 ์ข…ํ•ฉ ์ธ๊ธฐ๋„ ์ถœ์ „ ์ฐฉ์ˆœ ์ถœ์ฃผ 10 11 5 ๊ฒ€์€์š”์ • ๊ตญ5 ํ•œ2 ์•” ๊น€์žฌ์„ญ ์˜์ค€ 53 3์ฐฉ ์„ ํ–‰ 5 5 5 15 1 6 3 0.3 ์ฃผ 10 ๋žœ๋“œ๋ ˆ์ด๋”” ๊ตญ5 ํ•œ2 ์•” ๊ฐ•ํ˜•๊ณค ํ˜„๋ช… 53 3์ฐฉ ์„ ํ–‰ 10 5 6.3 10 10 4 8 4 2 4 ์ฃผ 11 ์ผ๋งฅ์ƒํ†ต ๊ตญ5 ํ•œ3 ์•”

More information

440 ์ •ํ˜„์žฌ ๊น€์„ฑ๋‚จ ์ด์€ํฌ์™ธ 6 ์ธ ๋‚ด HPV DNA ๊ฒ€์‚ฌ์‹œ์—๋Š” hybrid capture assay, HPV DNA chip (microarray) ๋“ฑ์„์ฃผ๋กœ์‚ฌ์šฉํ•˜๊ณ ์žˆ๋‹ค Matrix-assisted laser desorption ionization time

440 ์ •ํ˜„์žฌ ๊น€์„ฑ๋‚จ ์ด์€ํฌ์™ธ 6 ์ธ ๋‚ด HPV DNA ๊ฒ€์‚ฌ์‹œ์—๋Š” hybrid capture assay, HPV DNA chip (microarray) ๋“ฑ์„์ฃผ๋กœ์‚ฌ์šฉํ•˜๊ณ ์žˆ๋‹ค Matrix-assisted laser desorption ionization time The Korean Journal of Pathology 2006; 40: 439-47 ์ž๊ถ๊ฒฝ๋ถ€์„ธํฌ์ง„๊ฒ€์‚ฌ์ด์ƒ๊ณผ์ž๊ถ๊ฒฝ๋ถ€์ข…์–‘์†Œ๊ฒฌ์„๋ณด์ธํ™˜์ž์—๊ฒŒ์„œ์ œํ•œํšจ์†Œ์งˆ๋Ÿ‰๋‹คํ˜•์„ฑ๋ถ„์„๊ณผ DNA chip์„ํ†ตํ•œ์ธ์œ ๋‘์ข…๋ฐ”์ด๋Ÿฌ์Šค์œ ์ „์žํ˜•๊ฒ€์‚ฌ์˜์œ ์šฉ์„ฑ๋น„๊ต ์ •ํ˜„์žฌ ๊น€์„ฑ๋‚จ 1 ์ด์€ํฌ 1 ์ง€๋ฏธ์„  1 ๊น€๋ฏผ์•„ 2 ํ™ฉ์„ ์˜ ์กฐํฌ์ • ๊น€์ˆ˜์˜ฅํ™์„ ํ‘œ ( ์ฃผ ) ์ง„๋งคํŠธ๋ฆญ์Šค์ค‘์•™์—ฐ๊ตฌ์†Œ 1 ๋…น์‹ญ์ž์˜๋ฃŒ์žฌ๋‹จ์ง„๋‹จ๊ฒ€์‚ฌ์˜ํ•™๊ณผ 2

More information

04_์ด๊ทผ์›_21~27.hwp

04_์ด๊ทผ์›_21~27.hwp 1) KIGAS Vol. 16, No. 5, pp 21~27, 2012 (Journal of the Korean Institute of Gas) http://dx.doi.org/10.7842/kigas.2012.16.5.21 ์‹คํ—˜์‹ค์˜ ์‚ฌ๋ก€ ๋ถ„์„์— ๊ด€ํ•œ ์—ฐ๊ตฌ ์ด๊ทผ์› ์ด์ •์„ ํ•œ๊ตญ์‚ฐ์—…์•ˆ์ „๋ณด๊ฑด๊ณต๋‹จ ์‚ฐ์—…์•ˆ์ „๋ณด๊ฑด์—ฐ๊ตฌ์› (2012๋…„ 9์›” 5์ผ ํˆฌ๊ณ , 2012๋…„ 10์›” 19์ผ

More information

( )Jkstro011.hwp

( )Jkstro011.hwp ๋น„์ธ๊ฐ•์•”์˜๋ฐฉ์‚ฌ์„ ์น˜๋ฃŒ๊ฒฐ๊ณผ๋ฐ์ƒ์กด์œจ์—๊ด€ํ•œ์˜ˆํ›„์ธ์ž๋ถ„์„ 2005 2 1 2005 3 28. :, Tel: 053)250-7665, Fax: 053)250-7984 E-mail: jhkim@dsmc.or.kr ์ •์˜์—ฐ์™ธ 2 ์ธ : ๋น„์ธ๊ฐ•์•”์˜์˜ˆํ›„์ธ์ž๋ถ„์„ ์ •์˜์—ฐ์™ธ 2 ์ธ : ๋น„์ธ๊ฐ•์•”์˜์˜ˆํ›„์ธ์ž๋ถ„์„ Carcinoma of the nasopharynx treated by radiotherapy

More information

untitled

untitled World Report 2010 Inside K-sure Biz and Life 2010 11.12 164 World Report 2010 06 12 18 22 26 Inside K-sure 28 34 40 46 50 58 62 Biz and Life 64 66 Global Standard 68 70 Green Economy 72 Rival Game 74

More information

๋…ธ์ธ์ •์‹ ์˜ํ•™ํšŒ๋ณด14-1ํ˜ธ

๋…ธ์ธ์ •์‹ ์˜ํ•™ํšŒ๋ณด14-1ํ˜ธ ์ œ14๊ถŒ 1ํ˜ธ ํ†ต๊ถŒ ์ œ23ํ˜ธ www.kagp.or.kr ๋ฐœํ–‰์ธ : ์ •์ธ๊ณผ / ํŽธ์ง‘์ธ : ์ด๋™์šฐ / ๋ฐœํ–‰์ฒ˜ : ์ •์ธ๊ณผ (152-703) ์„œ์šธํŠน๋ณ„์‹œ ๊ตฌ๋กœ๊ตฌ ๊ตฌ๋กœ๋™ 80๋ฒˆ์ง€ ๊ณ ๋ ค๋Œ€ํ•™๊ต ๊ตฌ๋กœ๋ณ‘์› ์ •์‹ ๊ณผ / TEL : 02-818-6608 / FAX : 02-852-1937 ๋ฐœํ–‰์ผ : 2008๋…„ 4์›” 30์ผ / ์ œ ์ž‘ : (์ฃผ)์— ์—˜์ปค๋ฎค๋‹ˆ์ผ€์ด์…˜ 140-846 ์„œ์šธํŠน๋ณ„์‹œ

More information

386-390.hwp

386-390.hwp 386 HANYANG MEDICAL REVIEWS Vol. 29 No. 4, 2009 ์šฐ๋ฆฌ๋‚˜๋ผ ๋ฏธ์ˆ™์•„์˜ ํ†ต๊ณ„์™€ ์˜๋ฃŒ๋น„์šฉ Statistics and Medical Cost of Preterm in Korea ์œคํ˜œ์„  ์„์ง€๋Œ€ํ•™๊ต ๋…ธ์›์„์ง€๋ณ‘์› ์†Œ์•„์ฒญ์†Œ๋…„๊ณผํ•™๊ต์‹ค Hye Sun Yoon, M.D., Ph.D., Department of Pediatrics, Nowon

More information

Kor. J. Aesthet. Cosmetol., ๋ฐ ์ž์•„์กด์ค‘๊ฐ๊ณผ ์ŠคํŠธ๋ ˆ์Šค์™€๋„ ๋ฐ€์ ‘ํ•œ ๊ด€๊ณ„๊ฐ€ ์žˆ๊ณ , ๋งŒ์กฑ ์ •๋„ ์— ๋”ฐ๋ผ ์ „๋ฐ˜์ ์ธ ์ƒํ™œ์—๋„ ์˜ํ–ฅ์„ ๋ฏธ์น˜๋ฏ€๋กœ ์‹ ์ฒด๋Š” ๊ฐˆ์ˆ˜๋ก ๊ฐœ ์ธ์ , ์‚ฌํšŒ์  ์ฐจ์›์—์„œ ์ค‘์š”ํ•ด์ง€๊ณ  ์žˆ๋‹ค(์•ˆํฌ์ง„, 2010). ๋”ฐ๋ผ์„œ ์™ธ๋ชจ๋งŒ์กฑ๋„๋Š” ๊ฐœ์ธ์˜ ์‹ ์ฒด๋Š” ํƒ€

Kor. J. Aesthet. Cosmetol., ๋ฐ ์ž์•„์กด์ค‘๊ฐ๊ณผ ์ŠคํŠธ๋ ˆ์Šค์™€๋„ ๋ฐ€์ ‘ํ•œ ๊ด€๊ณ„๊ฐ€ ์žˆ๊ณ , ๋งŒ์กฑ ์ •๋„ ์— ๋”ฐ๋ผ ์ „๋ฐ˜์ ์ธ ์ƒํ™œ์—๋„ ์˜ํ–ฅ์„ ๋ฏธ์น˜๋ฏ€๋กœ ์‹ ์ฒด๋Š” ๊ฐˆ์ˆ˜๋ก ๊ฐœ ์ธ์ , ์‚ฌํšŒ์  ์ฐจ์›์—์„œ ์ค‘์š”ํ•ด์ง€๊ณ  ์žˆ๋‹ค(์•ˆํฌ์ง„, 2010). ๋”ฐ๋ผ์„œ ์™ธ๋ชจ๋งŒ์กฑ๋„๋Š” ๊ฐœ์ธ์˜ ์‹ ์ฒด๋Š” ํƒ€ RESEARCH ARTICLE Kor. J. Aesthet. Cosmetol., 20-40๋Œ€ ์—ฌ์„ฑ์˜ ์™ธ๋ชจ๋งŒ์กฑ๋„๊ฐ€ ๋ฏธ์šฉ๊ด€๋ฆฌํƒœ๋„์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ ํ™์ˆ˜๋‚จ 1, ๊น€ํšจ์ˆ™ 2 * 1 ๊ฑด๊ตญ๋Œ€ํ•™๊ต ๋ทฐํ‹ฐ์‚ฌ์ด์–ธ์Šค๋””์ž์ธํ•™๊ณผ, 2 ๊ฑด๊ตญ๋Œ€ํ•™๊ต ์˜์ƒ๋””์ž์ธ๊ณผ Effects of Extrinsic Body Satisfaction on Beauty Management Behavior of

More information

3542 KS Figure 1 ์›/์—” ํ™˜์œจ ์ถ”์ด Figure 2 ๋ผ์ธ 2Q ~ 3Q15 ๋งค์ถœ breakdown (KRW/JPY) 13 12 12 (KRW bn) 3 25 Total: 229 Total: 254 11 FX 11 11 1 1 2 15 1 84 91 (+9%

3542 KS Figure 1 ์›/์—” ํ™˜์œจ ์ถ”์ด Figure 2 ๋ผ์ธ 2Q ~ 3Q15 ๋งค์ถœ breakdown (KRW/JPY) 13 12 12 (KRW bn) 3 25 Total: 229 Total: 254 11 FX 11 11 1 1 2 15 1 84 91 (+9% Company update Korea / Internet & Game 9 September 215 BUY ๋ชฉํ‘œ์ฃผ๊ฐ€ ํ˜„์žฌ์ฃผ๊ฐ€ (8 Sep 215) 72, ์› 461,5 ์› Upside/downside (%) 51.7 KOSPI 1,883.22 ์‹œ๊ฐ€์ด์•ก (์‹ญ์–ต์›) 15,641 52 ์ฃผ ์ตœ์ €/์ตœ๊ณ  466, - 834, ์ผํ‰๊ท ๊ฑฐ๋ž˜๋Œ€๊ธˆ (์‹ญ์–ต์›) 73.18 ์™ธ๊ตญ์ธ ์ง€๋ถ„์œจ

More information

๋‹น์‹ ์ด ๊ฟˆ๊พธ๋˜ ์ฑ„๋„, CONTENTS ์ฑ„๋„ํŒŒ์›Œ ๋ฐ์ดํ„ฐ๋กœ ์‚ดํŽด๋ณด๋Š” Buying Point ํŠน๋ณ„๋ถ„์„ : ๋น…๋ฐ์ดํ„ฐ๋กœ ๋ถ„์„ํ•œ ๋‹น์‹ ์ด ๋ชฐ๋ž๋˜ ๋‹น์‹ ์ด ๊ฟˆ๊พธ๋˜ ์ฑ„๋„, - ์ฑ„๋„ํŒŒ์›Œ - ๋ฐ์ดํ„ฐ๋กœ ์‚ดํŽด๋ณด๋Š” Buying Point - ํŠน๋ณ„๋ถ„์„ : ๋น…๋ฐ์ดํ„ฐ๋กœ ๋ถ„์„ํ•œ ๋‹น์‹ ์ด ๋ชฐ๋ž๋˜ 02 06

๋‹น์‹ ์ด ๊ฟˆ๊พธ๋˜ ์ฑ„๋„, CONTENTS ์ฑ„๋„ํŒŒ์›Œ ๋ฐ์ดํ„ฐ๋กœ ์‚ดํŽด๋ณด๋Š” Buying Point ํŠน๋ณ„๋ถ„์„ : ๋น…๋ฐ์ดํ„ฐ๋กœ ๋ถ„์„ํ•œ ๋‹น์‹ ์ด ๋ชฐ๋ž๋˜ ๋‹น์‹ ์ด ๊ฟˆ๊พธ๋˜ ์ฑ„๋„, - ์ฑ„๋„ํŒŒ์›Œ - ๋ฐ์ดํ„ฐ๋กœ ์‚ดํŽด๋ณด๋Š” Buying Point - ํŠน๋ณ„๋ถ„์„ : ๋น…๋ฐ์ดํ„ฐ๋กœ ๋ถ„์„ํ•œ ๋‹น์‹ ์ด ๋ชฐ๋ž๋˜ 02 06 ๋‹น์‹ ์ด ๊ฟˆ๊พธ๋˜ ์ฑ„๋„ ๋‹น์‹ ์ด ๊ฟˆ๊พธ๋˜ ์ฑ„๋„, CONTENTS ์ฑ„๋„ํŒŒ์›Œ ๋ฐ์ดํ„ฐ๋กœ ์‚ดํŽด๋ณด๋Š” Buying Point ํŠน๋ณ„๋ถ„์„ : ๋น…๋ฐ์ดํ„ฐ๋กœ ๋ถ„์„ํ•œ ๋‹น์‹ ์ด ๋ชฐ๋ž๋˜ ๋‹น์‹ ์ด ๊ฟˆ๊พธ๋˜ ์ฑ„๋„, - ์ฑ„๋„ํŒŒ์›Œ - ๋ฐ์ดํ„ฐ๋กœ ์‚ดํŽด๋ณด๋Š” Buying Point - ํŠน๋ณ„๋ถ„์„ : ๋น…๋ฐ์ดํ„ฐ๋กœ ๋ถ„์„ํ•œ ๋‹น์‹ ์ด ๋ชฐ๋ž๋˜ 02 06 ๋‹น์‹ ์˜ ๋ธŒ๋žœ๋“œ ๊ฐ€์น˜๋ฅผ ์˜ฌ๋ ค์ค„ ํ”„๋กœ๊ทธ๋žจ - ์œ ์•„/์ฃผ๋ถ€ํƒ€๊นƒ ์ตœ๊ณ  ๊ด‘๊ณ ํšจ๊ณผ,

More information

03์ด๊ฒฝ๋ฏธ(237~248)ok

03์ด๊ฒฝ๋ฏธ(237~248)ok The recent (2001-2010) changes on temperature and precipitation related to normals (1971-2000) in Korea* Kyoungmi Lee** Hee-Jeong Baek*** ChunHo Cho**** Won-Tae Kwon*****. 61 (1971~2000) 10 (2001~2010).

More information

Microsoft Word - KIS_Touchscreen_5Apr11_K_2.doc

Microsoft Word - KIS_Touchscreen_5Apr11_K_2.doc ์‚ฐ์—…๋ถ„์„ Report / ํ„ฐ์น˜์Šคํฌ๋ฆฐ 211. 4. 5 ๋น„์ค‘ํ™•๋Œ€(์‹ ๊ทœ) ์ข…๋ชฉ ํˆฌ์ž์˜๊ฒฌ ๋ชฉํ‘œ์ฃผ๊ฐ€(์›) ๋ฉœํŒŒ์Šค(9664) ๋งค์ˆ˜(-) 67,( ) ์ผ์ง„๋””์Šคํ”Œ๋ ˆ์ด(276) ๋งค์ˆ˜(์‹ ๊ทœ) 14,5(-) ์—์Šค๋งฅ(9778) ๋งค์ˆ˜(์‹ ๊ทœ) 18,(-) ์ด์—˜์ผ€์ด(9419) ๋งค์ˆ˜(-) 27,( ) ์‚ผ์„ฑ์ „์ž ํƒœ๋ธ”๋ฆฟ PC ๊ณต๊ธ‰์—…์ฒด์— ์ฃผ๋ชฉ ํ„ฐ์น˜์Šคํฌ๋ฆฐ ์‚ฐ์—… ์˜ฌํ•ด 9% YoY ์„ฑ์žฅ ๋น„์ค‘ํ™•๋Œ€

More information

<30312EC1BEBCB32DB1E8B1E2C5C22E687770>

<30312EC1BEBCB32DB1E8B1E2C5C22E687770> Korean Journal of Obstetrics and Gynecology Vol. 53 No. 4 April 2010 ์ „์•”๋ณ‘๋ณ€์„๊ฐ€์ง„๋ถ€์ธ๊ณผํ™˜์ž์˜์ฒ˜์น˜ ์ธ์ œ๋Œ€ํ•™๊ต์˜๊ณผ๋Œ€ํ•™๋ถ€์‚ฐ๋ฐฑ๋ณ‘์›์‚ฐ๋ถ€์ธ๊ณผ 1, ๋ฐฑ์ธ์ œ๊ธฐ๋…์ž„์ƒ์˜ํ•™์—ฐ๊ตฌ์†Œ 2 ์ •๋Œ€ํ›ˆ 1,2 ์ด๊ฒฝ๋ณต 1 ๊น€๊ธฐํƒœ 1,2 Management of gynecologic patients with precancerous disease

More information

Treatment and Role of Hormaonal Replaement Therapy

Treatment and Role of Hormaonal Replaement Therapy Treatment and Role of Hormone Replacement Therapy Chung-Ang University Hospital Chee Jeong Kim 7.2 5.3 6.4 5.6 7.3 5.5 1 1 2 3 4 10 11 7 34 49 122 123 1.0 - - 10. 2001 1998 1998 Improvement of postmenopausal

More information

<31372DB9DABAB4C8A32E687770>

<31372DB9DABAB4C8A32E687770> ๊น€๊ฒฝํ™˜ ๋ฐ•๋ณ‘ํ˜ธ ์ถฉ๋ถ๋Œ€ํ•™๊ต ๋„์‹œ๊ณตํ•™๊ณผ (2010. 5. 27. ์ ‘์ˆ˜ / 2011. 11. 23. ์ฑ„ํƒ) Developing the Traffic Severity by Type Kyung-Hwan Kim Byung Ho Park Department of Urban Engineering, Chungbuk National University (Received May

More information

example code are examined in this stage The low pressure pressurizer reactor trip module of the Plant Protection System was programmed as subject for

example code are examined in this stage The low pressure pressurizer reactor trip module of the Plant Protection System was programmed as subject for 2003 Development of the Software Generation Method using Model Driven Software Engineering Tool,,,,, Hoon-Seon Chang, Jae-Cheon Jung, Jae-Hack Kim Hee-Hwan Han, Do-Yeon Kim, Young-Woo Chang Wang Sik, Moon

More information

Vol.259 C O N T E N T S M O N T H L Y P U B L I C F I N A N C E F O R U M

Vol.259 C O N T E N T S M O N T H L Y P U B L I C F I N A N C E F O R U M 2018.01 Vol.259 C O N T E N T S 02 06 28 61 69 99 104 120 M O N T H L Y P U B L I C F I N A N C E F O R U M 2 2018.1 3 4 2018.1 1) 2) 6 2018.1 3) 4) 7 5) 6) 7) 8) 8 2018.1 9 10 2018.1 11 2003.08 2005.08

More information

์ž์—ฐ์ฑ„๋ฌด์—๋Œ€ํ•œ์žฌ๊ฒ€ํ†  1. ์„œ๋ก  2. ์„ ํ–‰์—ฐ๊ตฌ 9 Journal of Digital Convergence 214 May; 12(5): 89-99

์ž์—ฐ์ฑ„๋ฌด์—๋Œ€ํ•œ์žฌ๊ฒ€ํ†  1. ์„œ๋ก  2. ์„ ํ–‰์—ฐ๊ตฌ 9 Journal of Digital Convergence 214 May; 12(5): 89-99 ์ข…ํ•ฉ์ฃผ๊ฐ€์ง€์ˆ˜ ์„œ์šธ์ง€์—ญ์•„ํŒŒํŠธ๊ฐ€๊ฒฉ ์ „๊ตญ์ฃผํƒ๋งค๋งค๊ฐ€๊ฒฉ์ง€์ˆ˜ ๊ฒฝ๊ธฐ์„ ํ–‰์ง€์ˆ˜์˜์ƒ๊ด€๊ด€๊ณ„์™€์„ ํ–‰์„ฑ๋ถ„์„ ์ตœ์ •์ผ *, ์ด์˜ฅ๋™ ์„ฑ๊ฒฐ๋Œ€ํ•™๊ต๊ฒฝ์˜๋Œ€ํ•™ *, ์„ฑ๊ฒฐ๋Œ€ํ•™๊ต๋ถ€๋™์‚ฐํ•™๊ณผ ** ** ์š”์•ฝ์ฃผ์‹์‹œ์žฅ์—์„œ์ข…ํ•ฉ์ฃผ๊ฐ€์ง€์ˆ˜๋ฅผ๋ถ€๋™์‚ฐ์‹œ์žฅ์—์„œ์„œ์šธ์ง€์—ญ์•„ํŒŒํŠธ๊ฐ€๊ฒฉ๊ณผ์ „๊ตญ์ฃผํƒ๋งค๋งค๊ฐ€๊ฒฉ์ง€์ˆ˜๋ฅผ์„ ์ •ํ•˜์—ฌ๊ฒฝ๊ธฐ ์„ ํ–‰์ง€์ˆ˜์™€ํ•จ๊ป˜๊ฐ์ง€ํ‘œ๋“ค์‚ฌ์ด์˜์ƒ๊ด€๊ด€๊ณ„๋ฅผ์ฐพ์•„๋ณด์•˜๋‹ค ๋˜ํ•œ๊ฐ์ง€ํ‘œ๋“ค์‚ฌ์ด์˜ํ๋ฆ„์„์„œ๋กœ๋น„๊ตํ•˜์—ฌ์„ ํ–‰์„ฑ์ด ์„ฑ๋ฆฝ๋˜๋Š”์ง€๋„์‚ดํŽด๋ณด์•˜๋‹ค๋ณธ์—ฐ๊ตฌ์˜๋ชฉ์ ์€์ข…ํ•ฉ์ฃผ๊ฐ€์ง€์ˆ˜์™€์„œ์šธ์ง€์—ญ์•„ํŒŒํŠธ๊ฐ€๊ฒฉ์ „๊ตญ์ฃผํƒ๋งค๋งค๊ฐ€๊ฒฉ๊ฒฝ๊ธฐ์„ ํ–‰์ง€์ˆ˜์˜

More information

Kor. J. Aesthet. Cosmetol., ๋ผ์ดํ”„์Šคํƒ€์ผ์€ ๊ฐœ์ธ ์ƒํ™œ์— ์žˆ์–ด ์‹ฌ๋ฆฌ์  ๋ฌธํ™”์  ์‚ฌํšŒ์  ๋ชจ๋“  ์ธก๋ฉด์˜ ์ƒํ™œ๋ฐฉ์‹๊ณผ ์ฐจ์ด ์ „์ฒด๋ฅผ ๋งํ•œ๋‹ค. ์ด๋Ÿฌํ•œ ๋ผ์ดํ”„์Šค ํƒ€์ผ์€ ์‚ฌ๋žŒ์˜ ๋‚ด์žฌ๋œ ๊ฐ€์น˜๊ด€์ด๋‚˜ ์š•๊ตฌ, ํ–‰๋™ ๋ณ€ํ™”๋ฅผ ํŒŒ์•…ํ•˜์—ฌ ์†Œ๋น„ํ–‰๋™๊ณผ ์‹ฌ๋ฆฌ๋ฅผ ์ถ”์ธกํ•  ์ˆ˜ ์žˆ๊ณ , ๊ฐœ์ธ์˜

Kor. J. Aesthet. Cosmetol., ๋ผ์ดํ”„์Šคํƒ€์ผ์€ ๊ฐœ์ธ ์ƒํ™œ์— ์žˆ์–ด ์‹ฌ๋ฆฌ์  ๋ฌธํ™”์  ์‚ฌํšŒ์  ๋ชจ๋“  ์ธก๋ฉด์˜ ์ƒํ™œ๋ฐฉ์‹๊ณผ ์ฐจ์ด ์ „์ฒด๋ฅผ ๋งํ•œ๋‹ค. ์ด๋Ÿฌํ•œ ๋ผ์ดํ”„์Šค ํƒ€์ผ์€ ์‚ฌ๋žŒ์˜ ๋‚ด์žฌ๋œ ๊ฐ€์น˜๊ด€์ด๋‚˜ ์š•๊ตฌ, ํ–‰๋™ ๋ณ€ํ™”๋ฅผ ํŒŒ์•…ํ•˜์—ฌ ์†Œ๋น„ํ–‰๋™๊ณผ ์‹ฌ๋ฆฌ๋ฅผ ์ถ”์ธกํ•  ์ˆ˜ ์žˆ๊ณ , ๊ฐœ์ธ์˜ RESEARCH ARTICLE Kor. J. Aesthet. Cosmetol., ํ•œ๊ตญ ์ค‘๋…„ ์—ฌ์„ฑ์˜ ๋ผ์ดํ”„์Šคํƒ€์ผ์ด ๋ฉ”์ดํฌ์—… ์ถ”๊ตฌ์ด๋ฏธ์ง€์™€ ํ™”์žฅํ’ˆ ๊ตฌ๋งคํ–‰๋™์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ ์ฃผ์˜์ฃผ 1 *, ์ด์ˆœํฌ 2 1 ์„œ๊ฒฝ๋Œ€ํ•™๊ต๋Œ€ํ•™์›๋ฏธ์šฉ์˜ˆ์ˆ ํ•™๊ณผ, 2 ์‹ ์„ฑ๋Œ€ํ•™๊ต ๋ฏธ์šฉ์˜ˆ์ˆ ๊ณ„์—ด The Effects of The Life Style for Korean Middle Aged Women on

More information

The Third NTCIR Workshop, Sep

The Third NTCIR Workshop, Sep 2003 National Institute of Informatics The Third NTCIR Workshop, Sep.2001 - Oct. 2002 The Third NTCIR Workshop, Sep.2001 - Oct. 2002 The Third NTCIR Workshop, Sep.2001 - Oct. 2002 The Third NTCIR Workshop,

More information

untitled

untitled ์ œ 1 ์„ธ๋ถ€๊ณผ์ œ ์•ˆ์ „ํ•œ ์˜ˆ๋ฐฉ์ ‘์ข… ์‹ค์ฒœ์„ ์œ„ํ•œ ์ „๋žต ๋ฐ ๊ต์œก, ํ™๋ณด ์ž๋ฃŒ ๊ฐœ๋ฐœ ์ œ 1 ์žฅ. ์„œ ๋ก  ์ œ 1 ์ ˆ. ์—ฐ๊ตฌ์˜ ํ•„์š”์„ฑ ๊ตญ๊ฐ€์ ์ธ ์ฐจ์›์—์„œ ์˜ˆ๋ฐฉ์ ‘์ข… ์‚ฌ์—…์€ ์ „์—ผ๋ณ‘ ๊ด€๋ฆฌ๋ฅผ ์œ„ํ•œ ๊ฐ€์žฅ ์ค‘์š”ํ•œ ๋ฐฉ์—ญ ์‚ฌ์—… ์ค‘ ํ•˜๋‚˜๋กœ, ๋Œ€๋‹ค์ˆ˜์˜ ์ „์—ผ๋ณ‘ ๋ฐœ์ƒ๋ฅ ์€ ๊ฐ์ข… ์ „์—ผ๋ณ‘์˜ ๋ฐฑ์‹ ์ด ๋‚˜์˜จ ํ›„๋กœ ํ˜„์ €ํžˆ ๊ฐ์†Œํ•˜์˜€์œผ๋ฉฐ, ์ธ๋ฅ˜ ์—ญ์‚ฌ์ƒ ๊ฐ€์žฅ ๋งŽ์€ ์ƒ๋ช…์„ ์ „์—ผ๋ณ‘์œผ๋กœ๋ถ€ํ„ฐ ๊ตฌ์›ํ•ด์ฃผ์—ˆ๋‹ค. ๊ทธ๋Ÿฌ๋‚˜,

More information

A 617

A 617 Special Issue Diabetic Retinopathy Won Ki Lee, M.D. Department of Ophthalmology The Catholic University of Korea College of Medicine Kangnam St. Mary s Hospital E mail : wklee@catholic.ac.kr Abstract R

More information

975_983 ํŠน์ง‘-ํ•œ๊ทœ์ฒ , ์ •์›ํ˜ธ

975_983 ํŠน์ง‘-ํ•œ๊ทœ์ฒ , ์ •์›ํ˜ธ Focused Issue of This Month Gyu Cheol an, MD Department of Otolaryngology ead & Neck Surgery, Gachon University of College Medicine E - mail : han@gilhospital.com Won-o Jung, MD Department of Otolaryngology

More information

ร€ร‡ร‡รยฐ๏ฟฝรร‚c00รŒยปรณร€รห˜

ร€ร‡ร‡รยฐ๏ฟฝรร‚c00รŒยปรณร€รห˜ Common Allergic Diseases in Children Sang - Il Lee, M.D. Department of pediatrics Sungkyunkwan University School of Medicine, Samsung Medical Center E - mail : silee@smc.samsung.co.kr Abstract Allergy

More information

DBPIA-NURIMEDIA

DBPIA-NURIMEDIA The e-business Studies Volume 17, Number 6, December, 30, 2016:237~251 Received: 2016/11/20, Accepted: 2016/12/24 Revised: 2016/12/21, Published: 2016/12/30 [ABSTRACT] Recently, there is an increasing

More information

- iii - - i - - ii - - iii - ๊ตญ๋ฌธ์š”์•ฝ ์ข…ํ•ฉ๋ณ‘์›๋‚จ์ž๊ฐ„ํ˜ธ์‚ฌ๊ฐ€์ง€๊ฐํ•˜๋Š”์กฐ์ง๊ณต์ •์„ฑ ์‚ฌํšŒ์ •์ฒด์„ฑ๊ณผ ์กฐ์ง์‹œ๋ฏผํ–‰๋™๊ณผ์˜๊ด€๊ณ„ - iv - - v - - 1 - - 2 - - 3 - - 4 - - 5 - - 6 - - 7 - - 8 - - 9 - - 10 - - 11 - - 12 - - 13 - - 14 - ฮฑ ฮฑ ฮฑ ฮฑ - 15 - ฮฑ ฮฑ ฮฑ ฮฑ ฮฑ ฮฑ

More information

<30352EB0A3BAB4B8AE2E687770>

<30352EB0A3BAB4B8AE2E687770> The Korean Journal of Hepatology 2007 ; 13 : 571-575 DOI: 10.3350/kjhep.2007.13.4.571 ์ด๋ฒˆ ํ˜ธ์˜ ๊ฐ„ ๋ณ‘๋ฆฌ(32) ํ˜ผํ•ฉ ๊ฐ„์„ธํฌ-๋‹ด๊ด€์„ธํฌ์•”์ข… ์ˆœ์ฒœํ–ฅ๋Œ€ํ•™๊ต๋ณ‘์› ๋ณ‘๋ฆฌ๊ณผ ์ง„์œค๋ฏธ ์ง„์†Œ์˜ Combined Hepatocellular-cholangiocarcinoma Yoon-Mi Jeen, M.D. and

More information

( )Kju225.hwp

( )Kju225.hwp ๋น„์ž„๊ท ์„ฑ๋น„๋‡จ์ƒ์‹๊ธฐ๊ฐ์—ผ์—์„œ ์˜์ง„๋‹จ์ ํšจ์šฉ์„ฑ Usefulness of the Mycofast Test (MYCOFAST Evolution 2) for the Diagnosis of Nongonococcal Genitourinary Infections Hang Ro Park, Yang Hyun Kim, Ho Jae Lee, Jea Sang Oh, Hyoung Jin

More information

<30382EC0C7C7D0B0ADC1C22E687770>

<30382EC0C7C7D0B0ADC1C22E687770> ๋Œ€ํ•œ๋‚ด๊ณผํ•™ํšŒ์ง€: ์ œ 76 ๊ถŒ ์ œ 2 ํ˜ธ 2009 ์˜ํ•™๊ฐ•์ขŒ-๊ฐœ์›์˜๋ฅผ ์œ„ํ•œ ๋ชจ๋ฒ”์ฒ˜๋ฐฉ(Current Clinical Practice) ๊ฐ„๊ธฐ๋Šฅ๊ฒ€์‚ฌ์˜ ์ดํ•ด์™€ ์ ์šฉ ์ธ์ œ๋Œ€ํ•™๊ต ์˜๊ณผ๋Œ€ํ•™ ์ผ์‚ฐ๋ฐฑ๋ณ‘์› ๋‚ด๊ณผํ•™๊ต์‹ค ๊น€ ๊ฒฝ ์•„ Understanding and application of liver function tests Kyung-Ah Kim, M.D. Department of

More information

untitled

untitled 14 13 12 11 (%) (SA, 2=1) YoY 3 2 1 1 9 8 7-1 -2 6 2 3 4 5 6 7 8 9-3 14 13 12 (%) (SA, 2=1) YoY 3 2 2.5 2 KOSPI Trailing PBR 199 11 1 1.5 1 9 8 7 6 2 3 4 5 6 7 8 9-1 -2-3 1.5 9.58 IT 4 9 92 94 96 98 2

More information

Manufacturing6

Manufacturing6 ฯƒ6 Six Sigma, it makes Better & Competitive - - 200138 : KOREA SiGMA MANAGEMENT C G Page 2 Function Method Measurement ( / Input Input : Man / Machine Man Machine Machine Man / Measurement Man Measurement

More information

<3037BFF8C0FA2DBEE7C1A4BCB12E687770>

<3037BFF8C0FA2DBEE7C1A4BCB12E687770> Korean Journal of Obstetrics and Gynecology Vol. 53 No. 12 December 2010 ์ž๊ถ๊ฒฝ๋ถ€์ƒํ”ผ๋‚ด์ข…์–‘์—์„œ์ธ์œ ๋‘์ข…๋ฐ”์ด๋Ÿฌ์Šค๊ฐ์—ผ๊ณผํด๋ผ๋ฏธ๋””์•„ํŠธ๋ผ์ฝ”๋งˆํ‹ฐ์Šค์˜๊ฐ์—ผ์—๋Œ€ํ•œ์ž„์ƒ์ ๊ณ ์ฐฐ ๋‹จ๊ตญ๋Œ€ํ•™๊ต์˜๊ณผ๋Œ€ํ•™์‚ฐ๋ถ€์ธ๊ณผํ•™๊ต์‹ค ์–‘์ •์„  ์ •์œคํฌ ๊น€์ข…์ˆ˜ The study of association between human papillomavirus

More information

Microsoft Word - 20160318180453480_6

Microsoft Word - 20160318180453480_6 Sector Report 2016.03.23 ์ธํ„ฐ๋„ท ์ธํ„ฐ๋„ท/๊ฒŒ์ž„ ๊ธฐ์—… 1๋ถ„๊ธฐ ์‹ค์  ๋ฐ ์ฃผ๊ฐ€ ์ „๋ง ์ธํ„ฐ๋„ท (OVERWEIGHT) What s new? Our view ์ข…๋ชฉ ํˆฌ์ž์˜๊ฒฌ ๋ชฉํ‘œ์ฃผ๊ฐ€ (์›) NAVER BUY (M) 800,000 (M) ์นด์นด์˜ค BUY (M) 140,000 (M) ์—”์”จ์†Œํ”„ํŠธ BUY (M) 320,000 (U) ์ปดํˆฌ์Šค BUY (M) 180,000

More information

DBPIA-NURIMEDIA

DBPIA-NURIMEDIA e- ๋น„์ฆˆ๋‹ˆ์Šค์—ฐ๊ตฌ (The e-business Studies) Volume 17, Number 1, February, 28, 2016:pp. 293~316 ISSN 1229-9936 (Print), ISSN 2466-1716 (Online) ์›๊ณ ์ ‘์ˆ˜์ผ์‹ฌ์‚ฌ ( ์ˆ˜์ • ) ๊ฒŒ์žฌํ™•์ •์ผ 2015. 12. 04 2015. 12. 24 2016. 02. 25 ABSTRACT

More information

8-VSB (Vestigial Sideband Modulation)., (Carrier Phase Offset, CPO) (Timing Frequency Offset),. VSB, 8-PAM(pulse amplitude modulation,, ) DC 1.25V, [2

8-VSB (Vestigial Sideband Modulation)., (Carrier Phase Offset, CPO) (Timing Frequency Offset),. VSB, 8-PAM(pulse amplitude modulation,, ) DC 1.25V, [2 VSB a), a) An Alternative Carrier Phase Independent Symbol Timing Offset Estimation Methods for VSB Receivers Sung Soo Shin a) and Joon Tae Kim a) VSB. VSB.,,., VSB,. Abstract In this paper, we propose

More information

Microsoft Word - 20150129080414253_1

Microsoft Word - 20150129080414253_1 Company Report 215.1.3 SKํ…”๋ ˆ์ฝค (1767) 4๋ถ„๊ธฐ ๋ฆฌ๋ทฐ : ์ฃผ์ฃผํ™˜์› ์ •์ฑ…๊ณผ ์ปค๋จธ์Šคํ”Œ๋žซํผ ์ „๋žต์„ ํ†ตํ•ด 1 / 1 ๋น„์ „ ๋‹ฌ์„ฑํ•œ๋‹ค ํ†ต์‹ ์„œ๋น„์Šค What s new? Our view ํˆฌ์ž์˜๊ฒฌ: BUY (M) ๋ชฉํ‘œ์ฃผ๊ฐ€: 38,์› (M) ์ฃผ๊ฐ€ (1/29) 284,์› ์ž๋ณธ๊ธˆ ์‹œ๊ฐ€์ด์•ก 446์–ต์› 229,318์–ต์› ์ฃผ๋‹น์ˆœ์ž์‚ฐ 26,398์› ๋ถ€์ฑ„๋น„์œจ 81.14%

More information

Journal of Educational Innovation Research 2018, Vol. 28, No. 1, pp DOI: A study on Characte

Journal of Educational Innovation Research 2018, Vol. 28, No. 1, pp DOI:   A study on Characte Journal of Educational Innovation Research 2018, Vol. 28, No. 1, pp.381-404 DOI: http://dx.doi.org/10.21024/pnuedi.28.1.201803.381 A study on Characteristics of Action Learning by Analyzing Learners Experiences

More information

ยฐร‡ยฐ๏ฟฝยฐรบรรบยบยด6-2รˆยฃ

ยฐร‡ยฐ๏ฟฝยฐรบรรบยบยด6-2รˆยฃ K O R E A C E N T E R S F O R D I S E A S E C O N T R O L & P R E V E N T I O N PHWR Vol. 6 No. 2 www.cdc.go.kr 2013 1 11 6 2 ISSN:2005-811X Flavivirus surveillance in mosquitoes collected from the quarantine

More information

09๊ตฌ์ž์šฉ(489~500)

09๊ตฌ์ž์šฉ(489~500) The Study on the Grid Size Regarding Spatial Interpolation for Local Climate Maps* Cha Yong Ku** Young Ho Shin*** Jae-Won Lee**** Hee-Soo Kim*****.,...,,,, Abstract : Recent global warming and abnormal

More information

๋ชฉ์ฐจ โ…ฐ โ…ฒ โ…ณ Abstract v โ…  โ…ก โ…ข i

๋ชฉ์ฐจ โ…ฐ โ…ฒ โ…ณ Abstract v โ…  โ…ก โ…ข i 11-1480523-000748-01 ๋ฐฐ๊ฒฝ์ง€์—ญ ( ๋ฐฑ๋ น๋„ ) ์—์„œ์˜ ๋Œ€๊ธฐ์˜ค์—ผ๋ฌผ์งˆํŠน์„ฑ์—ฐ๊ตฌ (โ…ข) ๊ธฐํ›„๋Œ€๊ธฐ์—ฐ๊ตฌ๋ถ€๋Œ€๊ธฐํ™˜๊ฒฝ์—ฐ๊ตฌ๊ณผ,,,,,,, โ…ข 2010 ๋ชฉ์ฐจ โ…ฐ โ…ฒ โ…ณ Abstract v โ…  โ…ก โ…ข i ๋ชฉ์ฐจ โ…ฃ ii ๋ชฉ์ฐจ iii ๋ชฉ์ฐจ iv ๋ชฉ์ฐจ ฮผg m3 ฮผg m3 v ๋ชฉ์ฐจ vi โ… . ์„œ๋ก  โ…  ฮผm ฮผg m3 1 โ… . ์„œ๋ก  ฮผg m3 ฮผg m3 ฮผg m3 ฮผm 2

More information

...... ....2-1

...... ....2-1 ,,,, (), pp. ~., TV (PPL) -,,, (), pp. ~., TV PPL, :.,, (), pp. ~., PPL,,, (), pp. ~., ( - ) PPL,,, (), pp. ~., (PPL) : PPL,,, (), pp. ~.,..., TV PPL,,, (), pp. ~.,,,,,, (), pp. ~.,,,.,... LG,... Babin,

More information

์Šคํฌ์ธ ๊ณผํ•™ 143ํ˜ธ ๋‚ด์ง€.indd

์Šคํฌ์ธ ๊ณผํ•™ 143ํ˜ธ ๋‚ด์ง€.indd https simtk.org,, sanghyuk0620@kspo.or.kr.... 48 SPORT SCIENCE . 33 55% 1 2 Iwamoto and Takeda 2003 3 1 3.......?... 4 SPORT SCIENCE 1. 2 3 12 16 3 6.. 5 strain gauge. 1970. 6 1) Brukner, P., Bradshaw,

More information

methods.hwp

methods.hwp 1. ๊ต๊ณผ๋ชฉ ๊ฐœ์š” ์‹ฌ๋ฆฌํ•™ ์—ฐ๊ตฌ์— ๊ธฐ์ €ํ•˜๋Š” ๊ธฐ๋ณธ ์›๋ฆฌ๋“ค์„ ์ดํ•ดํ•˜๊ณ , ๋‹ค์–‘ํ•œ ์‹ฌ๋ฆฌํ•™ ์—ฐ๊ตฌ์„ค๊ณ„(์‹คํ—˜ ๋ฐ ๋น„์‹คํ—˜ ์„ค๊ณ„)๋ฅผ ํ•™์Šตํ•˜์—ฌ, ๋…๋ฆฝ๋œ ์—ฐ๊ตฌ์ž๋กœ์„œ์˜ ๊ธฐ๋ณธ์ ์ธ ์—ฐ๊ตฌ ์„ค๊ณ„ ๋ฐ ํ†ต๊ณ„ ๋ถ„์„๋Šฅ๋ ฅ์„ ํ•จ์–‘ํ•œ๋‹ค. 2. ๊ฐ•์˜ ๋ชฉํ‘œ ์‹ฌ๋ฆฌํ•™ ์—ฐ๊ตฌ์ž๋กœ์„œ ๊ฐ–์ถ”์–ด์•ผ ํ•  ๊ธฐ๋ณธ์ ์ธ ์ง€์‹๋“ค์„ ์ตํž˜์„ ๋ชฉ์ ์œผ๋กœ ํ•œ๋‹ค. 3. ๊ฐ•์˜ ๋ฐฉ๋ฒ• ๊ฐ•์˜, ํ† ๋ก , ์กฐ๋ณ„ ๋ฐœํ‘œ 4. ํ‰๊ฐ€๋ฐฉ๋ฒ• ์ค‘๊ฐ„๊ณ ์‚ฌ 35%, ๊ธฐ๋ง๊ณ ์‚ฌ

More information